<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">78217</article-id><article-id pub-id-type="doi">10.7554/eLife.78217</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Contribution of <italic>Trp63<sup>CreERT2</sup></italic>-labeled cells to alveolar regeneration is independent of tuft cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-272318"><name><surname>Huang</surname><given-names>Huachao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272324"><name><surname>Fang</surname><given-names>Yinshan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9249-4498</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272319"><name><surname>Jiang</surname><given-names>Ming</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272320"><name><surname>Zhang</surname><given-names>Yihan</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272321"><name><surname>Biermann</surname><given-names>Jana</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8907-4633</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272322"><name><surname>Melms</surname><given-names>Johannes C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5410-6586</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272323"><name><surname>Danielsson</surname><given-names>Jennifer A</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272325"><name><surname>Yang</surname><given-names>Ying</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4197-6216</contrib-id><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-21433"><name><surname>Qiang</surname><given-names>Li</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8322-1797</contrib-id><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272326"><name><surname>Liu</surname><given-names>Jia</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272327"><name><surname>Zhou</surname><given-names>Yiwu</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-252300"><name><surname>Wang</surname><given-names>Manli</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123810"><name><surname>Hu</surname><given-names>Zhihong</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1560-0928</contrib-id><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272329"><name><surname>Wang</surname><given-names>Timothy C</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272330"><name><surname>Saqi</surname><given-names>Anjali</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231535"><name><surname>Sun</surname><given-names>Jie</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187832"><name><surname>Matsumoto</surname><given-names>Ichiro</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-136428"><name><surname>Cardoso</surname><given-names>Wellington V</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8868-9716</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272331"><name><surname>Emala</surname><given-names>Charles W</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-259879"><name><surname>Zhu</surname><given-names>Jian</given-names></name><xref ref-type="aff" rid="aff15">15</xref><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272332"><name><surname>Izar</surname><given-names>Benjamin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2379-6702</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con21"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-90658"><name><surname>Mou</surname><given-names>Hongmei</given-names></name><email>HMOU@mgh.harvard.edu</email><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con22"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-271644"><name><surname>Que</surname><given-names>Jianwen</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6540-6701</contrib-id><email>jq2240@columbia.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con23"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01esghr10</institution-id><institution>Columbia Center for Human Development, Department of Medicine, Columbia University Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01esghr10</institution-id><institution>Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/025fyfd20</institution-id><institution>Institute of Genetics, the Children's Hospital, Zhejiang University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/002pd6e78</institution-id><institution>Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Harvard Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hj8s172</institution-id><institution>Division of Hematology/Oncology, Department of Medicine, Columbia University Irving Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hj8s172</institution-id><institution>Columbia Center for Translational Immunology, Columbia University Irving Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hj8s172</institution-id><institution>Department of Anesthesiology, Columbia University Irving Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Program in Epithelial Biology, Stanford University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Stanford</named-content></addr-line><country>United States</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01esghr10</institution-id><institution>Department of Pathology &amp; Cell Biology, Columbia University Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/034t30j35</institution-id><institution>State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences</institution></institution-wrap><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff><aff id="aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00p991c53</institution-id><institution>Department of Forensic Medicine, Tongji Medical College of Huazhong University of Science and Technology</institution></institution-wrap><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff><aff id="aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0153tk833</institution-id><institution>Carter Immunology Center, the University of Virginia</institution></institution-wrap><addr-line><named-content content-type="city">Charlottesville</named-content></addr-line><country>United States</country></aff><aff id="aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01mdfdm06</institution-id><institution>Monell Chemical Senses Center</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01esghr10</institution-id><institution>Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Columbia University Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff15"><label>15</label><institution>Department of Pathology, Ohio State University College of Medicine</institution><addr-line><named-content content-type="city">Columbus</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Noble</surname><given-names>Paul W</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pammg90</institution-id><institution>Cedars-Sinai Medical Centre</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Noble</surname><given-names>Paul W</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pammg90</institution-id><institution>Cedars-Sinai Medical Centre</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>21</day><month>09</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e78217</elocation-id><history><date date-type="received" iso-8601-date="2022-02-27"><day>27</day><month>02</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-09-18"><day>18</day><month>09</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-03-12"><day>12</day><month>03</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.03.11.483948"/></event></pub-history><permissions><copyright-statement>© 2022, Huang et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Huang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-78217-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-78217-figures-v2.pdf"/><related-article related-article-type="article-reference" ext-link-type="doi" xlink:href="10.7554/eLife.78074" id="ra1"/><abstract><p>Viral infection often causes severe damage to the lungs, leading to the appearance of ectopic basal cells (EBCs) and tuft cells in the lung parenchyma. Thus far, the roles of these ectopic epithelial cells in alveolar regeneration remain controversial. Here, we confirm that the ectopic tuft cells are originated from EBCs in mouse models and COVID-19 lungs. The differentiation of tuft cells from EBCs is promoted by Wnt inhibition while suppressed by Notch inhibition. Although progenitor functions have been suggested in other organs, pulmonary tuft cells don’t proliferate or give rise to other cell lineages. Consistent with previous reports, <italic>Trp63<sup>CreERT2</sup></italic> and <italic>KRT5-CreERT2</italic>-labeled ectopic EBCs do not exhibit alveolar regeneration potential. Intriguingly, when tamoxifen was administrated post-viral infection, <italic>Trp63<sup>CreERT2</sup></italic> but not <italic>KRT5-CreERT2</italic> labels islands of alveolar epithelial cells that are negative for EBC biomarkers. Furthermore, germline deletion of <italic>Trpm5</italic> significantly increases the contribution of <italic>Trp63<sup>CreERT2</sup></italic>-labeled cells to the alveolar epithelium. Although Trpm5 is known to regulate tuft cell development, complete ablation of tuft cell production fails to improve alveolar regeneration in <italic>Pou2f3<sup>-/-</sup></italic> mice, implying that Trpm5 promotes alveolar epithelial regeneration through a mechanism independent of tuft cells.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>tuft cells</kwd><kwd>alveolar regeneration</kwd><kwd>viral infection</kwd><kwd>lung regeneration</kwd><kwd>COVID-19</kwd><kwd>basal cells</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>R01HL152293</award-id><principal-award-recipient><name><surname>Que</surname><given-names>Jianwen</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>R01HL159675</award-id><principal-award-recipient><name><surname>Que</surname><given-names>Jianwen</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R01DK120650</award-id><principal-award-recipient><name><surname>Que</surname><given-names>Jianwen</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R01DK100342</award-id><principal-award-recipient><name><surname>Que</surname><given-names>Jianwen</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000897</institution-id><institution>Cystic Fibrosis Foundation</institution></institution-wrap></funding-source><award-id>MOU19G0</award-id><principal-award-recipient><name><surname>Mou</surname><given-names>Hongmei</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008035</institution-id><institution>Harvard Stem Cell Institute</institution></institution-wrap></funding-source><award-id>SG-0120-19-00</award-id><principal-award-recipient><name><surname>Mou</surname><given-names>Hongmei</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001680</institution-id><institution>Charles H. Hood Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Mou</surname><given-names>Hongmei</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000005</institution-id><institution>U.S. Department of Defense</institution></institution-wrap></funding-source><award-id>W81XWH-21-1-0196</award-id><principal-award-recipient><name><surname>Huang</surname><given-names>Huachao</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>R21AI163753</award-id><principal-award-recipient><name><surname>Huang</surname><given-names>Huachao</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A population of p63<sup>+</sup> Krt5<sup>-</sup> epithelial cells contribute to alveolar regeneration independent of the presence of ectopic tuft cells following viral infection.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Postmortem examination of H1N1 influenza-infected lungs revealed extensive tissue remodeling accompanied by the presence of ectopic cytokeratin-5-positive (KRT5<sup>+</sup>) basal cells in the lung parenchyma (<xref ref-type="bibr" rid="bib42">Xi et al., 2017</xref>). These ectopic basal cells (EBCs) are also present in the mouse parenchyma following infection with modified H1N1 influenza PR8 virus or treatment with a high dose of bleomycin (<xref ref-type="bibr" rid="bib15">Kanegai et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">Vaughan et al., 2015</xref>; <xref ref-type="bibr" rid="bib42">Xi et al., 2017</xref>; <xref ref-type="bibr" rid="bib44">Yuan et al., 2019</xref>; <xref ref-type="bibr" rid="bib45">Zacharias et al., 2018</xref>; <xref ref-type="bibr" rid="bib46">Zuo et al., 2015</xref>). Initial studies suggest that these EBCs contribute to alveolar regeneration (<xref ref-type="bibr" rid="bib46">Zuo et al., 2015</xref>). However, studies from other groups suggest that EBCs do not meaningfully become alveolar epithelial cells, but rather provide structural supports to prevent the lung from collapsing (<xref ref-type="bibr" rid="bib4">Basil et al., 2020</xref>; <xref ref-type="bibr" rid="bib15">Kanegai et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">Vaughan et al., 2015</xref>).</p><p>Tuft cells are a minor cell population critical for chemosensory and relaying immune signals in multiple organs including the intestine and trachea (<xref ref-type="bibr" rid="bib12">Howitt et al., 2016</xref>; <xref ref-type="bibr" rid="bib26">Montoro et al., 2018</xref>; <xref ref-type="bibr" rid="bib40">von Moltke et al., 2016</xref>). In the intestine tuft cells serve as immune sentinels during parasitic infection (<xref ref-type="bibr" rid="bib9">Gerbe et al., 2016</xref>; <xref ref-type="bibr" rid="bib12">Howitt et al., 2016</xref>; <xref ref-type="bibr" rid="bib24">McGinty et al., 2020</xref>; <xref ref-type="bibr" rid="bib40">von Moltke et al., 2016</xref>). Responding to helminth infection, tuft cells release the alarmin interleukin (IL)–25 which activates type 2 innate lymphoid cells (ILC2s) and their secretion of IL-13, initiating type 2 immune response to eliminate parasitic infection (<xref ref-type="bibr" rid="bib9">Gerbe et al., 2016</xref>; <xref ref-type="bibr" rid="bib12">Howitt et al., 2016</xref>; <xref ref-type="bibr" rid="bib40">von Moltke et al., 2016</xref>). Tuft cells were initially identified in the rat trachea over six decades ago (<xref ref-type="bibr" rid="bib33">Rhodin and Dalhamn, 1956</xref>). However, we just have begun to appreciate their functions in the respiratory system (<xref ref-type="bibr" rid="bib2">Bankova et al., 2018</xref>; <xref ref-type="bibr" rid="bib38">Ualiyeva et al., 2020</xref>). Recent single-cell RNA sequencing confirmed the presence of tuft cells in the mouse trachea where they express several canonical genes, such as <italic>Alox5ap</italic>, <italic>Pou2f3</italic>, and <italic>Gfi1b</italic> (<xref ref-type="bibr" rid="bib26">Montoro et al., 2018</xref>). Following repeated allergen challenges, tuft cells expand and amplify immune reactions (<xref ref-type="bibr" rid="bib2">Bankova et al., 2018</xref>). Intriguingly, tuft cells were found ectopically present in the lung parenchyma, co-localized with EBCs following PR8 viral infection (<xref ref-type="bibr" rid="bib31">Rane et al., 2019</xref>). Although p63-expressing lineage-negative epithelial stem/progenitor cells (LNEPs) were considered as a source of tuft cells (<xref ref-type="bibr" rid="bib31">Rane et al., 2019</xref>), it is still unclear whether these p63<sup>+</sup> cells immediately give rise to tuft cells or through EBCs. More recently, we reported that ectopic tuft cells were also present in the parenchyma of COVID-19 lungs, and ablation of tuft cells dampens macrophage infiltration at the acute phase following viral infection in a mouse model (<xref ref-type="bibr" rid="bib25">Melms et al., 2021</xref>). However, the role of tuft cells in lung regeneration following viral infection remains undetermined.</p><p>In this study, we showed that EBCs served as the cell of origin for the ectopic tuft cells present in the parenchyma during viral infection. Upon screening multiple signaling pathways we identified that Notch inhibition blocked tuft cell derivation, while Wnt inhibition significantly enhanced tuft cell differentiation from EBCs. We then used multiple mouse models to demonstrate that <italic>Trp63<sup>CreERT2</sup></italic> labeled subpopulations of alveolar type 1 and 2 (AT1/AT2) cells during regeneration regardless of the presence of tuft cells in the parenchyma.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Tuft cells expanded in response to challenges with influenza, bleomycin, or naphthalene</title><p>Tuft cells are rarely present in the proximal airways of normal adult mice (<xref ref-type="bibr" rid="bib26">Montoro et al., 2018</xref>). However, they were present in the distal airways at birth when tuft cells were first detected (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>). Tuft cells continued to be present throughout the airways when examined at postnatal (P)10 and P20 but were no longer detected in the terminal bronchiole at P56 (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>). Notably, tuft cells reappeared in the terminal airways approximately 7 days post infection (dpi) with PR8 virus (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). The number of tuft cells also significantly increased in the large airways at 30 dpi (4.9±1.1 vs 25.7±3.3 per 1000 epithelial cells) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). As previously described, tuft cells were present in the EBC area (<xref ref-type="bibr" rid="bib25">Melms et al., 2021</xref>; <xref ref-type="bibr" rid="bib31">Rane et al., 2019</xref>). Further analysis revealed that tuft cells were first detected in the EBC area at approximately 15 dpi and peaked at 21 dpi (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). The numbers of tuft cells also expanded in the large airways following naphthalene (13.4±1.1 per 1000 epithelial cells) or bleomycin challenge (8.6±0.8 per 1000 epithelial cells) (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). In addition, tuft cells were ectopically present within EBCs 28 days following challenge with a high dose of bleomycin (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). These findings suggest that tuft cell expansion in the airways is a general response to lung injuries, and that severe injuries induce ectopic tuft cells in the parenchyma.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Tuft cells in homeostasis and their expansion in response to severe injuries.</title><p>(<bold>A</bold>) Tuft cells are present in the distal airways at P0, P10, P20 but not P56. n=4 for each group. (<bold>B</bold>) Quantification of tuft cells from panel (<bold>A</bold>). (<bold>C</bold>) Tuft cells expand in the large airway and are ectopically present in the terminal airways following viral infection. (<bold>D</bold>) Tuft cells expand in the airways following naphthalene and bleomycin challenge and are ectopically present in parenchyma following bleomycin challenge. Scale bars, 50 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78217-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Ectopic tuft cells appear after viral infection.</title><p>(<bold>A</bold>) Time course analysis of ectopic tuft cells in the lung parenchyma following viral infection. (<bold>B</bold>) Quantification of tuft cells in ectopic basal cells areas of lung parenchyma. Scale bars, 50 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78217-fig1-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-2"><title>The ectopic tuft cells in the parenchyma did not proliferate or give rise to other cell lineages</title><p>Previous studies suggest that Dclk1<sup>+</sup> cells serve as progenitor cells in the small intestine and pancreas (<xref ref-type="bibr" rid="bib22">May et al., 2008</xref>; <xref ref-type="bibr" rid="bib23">May et al., 2009</xref>; <xref ref-type="bibr" rid="bib41">Westphalen et al., 2016</xref>). We asked whether the ectopic tuft cells in the lung parenchyma also possess progenitor potential. We performed lineage tracing with a knock-in <italic>Pou2f3<sup>CreERT2</sup></italic> mouse line (<xref ref-type="bibr" rid="bib24">McGinty et al., 2020</xref>). Tuft cells (Dclk1<sup>+</sup>) in the large airways were specifically labeled with the lineage tracing maker (tdT<sup>+</sup>) upon three Tamoxifen (Tmx) injections into <italic>Pou2f3<sup>CreERT2</sup>;R26<sup>Ai14</sup></italic> mice (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Notably,~92% tdT<sup>+</sup> cells expressed Dclk1 in the trachea, whereas all tdT<sup>+</sup> cells expressed Dclk1 in the large intrapulmonary airways (<xref ref-type="fig" rid="fig2">Figure 2A</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). We then analyzed the mice challenged with PR8 virus. Tmx was continuously given from 14 to 27 dpi and the lungs were analyzed at 60 dpi (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). The majority (~93%) of the ectopic tuft cells were lineage labeled in the lung parenchyma of <italic>Pou2f3<sup>CreERT2</sup>;R26<sup>Ai14</sup></italic> mice (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). These labeled tuft cells solitarily distributed in the injured lung parenchyma (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), indicating that they had not undergone expansion. Consistently, none of the tuft cells was positive for the proliferation marker Ki67 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). To further test whether tuft cells give rise to other cell lineages, immunostaining with various cell type markers was performed, including Scgb1a1 (club cells), FoxJ1 (ciliated cells), and Clca3 (goblet cells). The results showed that tuft cells did not contribute to other cell types following a chasing period up to 60 days (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). These data suggest that tuft cells in the lung unlikely serve as progenitor cells.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Tuft cells in the parenchyma are derived from ectopic basal cells (EBCs) following H1N1 PR8 viral infection.</title><p>(<bold>A</bold>) <italic>Pou2f3<sup>CreERT2</sup>;R26<sup>Ai14</sup></italic> mouse line specifically labels Dclk1<sup>+</sup> tuft cells in the large airways at homeostasis. (<bold>B</bold>) Lineage tracing of Pou2f3<sup>+</sup> cells in the parenchyma after PR8 virus infection. Arrow indicates a tdT<sup>+</sup>Dclk1<sup>-</sup> cell. (<bold>C</bold>) Lineage labeled tuft cells do not contribute to other cell lineages, including Scgb1a1<sup>+</sup> club cells, FoxJ1<sup>+</sup> ciliated cells and Clca3<sup>+</sup> goblet cells. (<bold>D</bold>) Lineage tracing confirms that tuft cells are derived from EBCs in the lung parenchyma of <italic>Trp63<sup>CreERT2</sup>;R26<sup>Ai14</sup></italic> mice following PR8 infection. (<bold>E</bold>) Lineage tracing shows about 80% of tuft cells are derived from EBCs in the lung parenchyma of <italic>KRT5-CreERT2;R26<sup>Ai14</sup></italic> mice following PR8 infection. Data represent mean ± s.e.m. Scale bars, 20 μm (<bold>A</bold>) and 50 μm (B to G).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78217-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Tuft cells in the lung parenchyma are derived from ectopic basal cells (EBCs).</title><p>(<bold>A</bold>) Lineage tracing shows heterogeneity of tuft cells in the trachea of <italic>Pou2f3<sup>CreERT2</sup>;R26<sup>Ai14</sup></italic> mice. Note that some lineage labeled cells do not express Dclk1 (arrowhead in left panel). (<bold>B</bold>) Tuft cells do not proliferate when examined at days 15, 21, and 30 post-infection. (<bold>C</bold>) ~5% of tuft cells within EBCs co-express Krt5 and Dclk1. (<bold>D</bold>) Lineage labeled cells contribute to ~21% ectopic tuft cells in the lung parenchyma of <italic>Scgb1a1<sup>CreERT</sup>;R26<sup>Ai14</sup></italic> mice. Scale bars, 50 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78217-fig2-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>The ectopic tuft cells in the parenchyma originated from EBCs in PR8-infected mice and COVID-19 lungs</title><p>Basal cells serve as the origin of tuft cells in the mouse trachea (<xref ref-type="bibr" rid="bib26">Montoro et al., 2018</xref>). By contrast, p63-expressing lineage-negative epithelial stem/progenitor cells (LNEPs) were considered as the origin of tuft cells in the lung parenchyma following viral infection (<xref ref-type="bibr" rid="bib31">Rane et al., 2019</xref>). While characterizing ectopic tuft cells in the parenchyma, we noticed approximately 5% tuft cells co-expressed Dclk1 and the basal cell marker Krt5 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>), suggesting that these tuft cells are in a transitioning state from EBCs towards tuft cells. To test this hypothesis, <italic>Trp63<sup>CreERT2</sup>;R26<sup>Ai14</sup></italic> mice were infected with PR8 virus followed by daily Tmx injection from 14 dpi to 18 dpi as tuft cells were initially detected at around 15 dpi (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). The majority of tuft cells within EBCs were labeled with tdT (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). We also used <italic>KRT5-CreERT2;R26<sup>Ai14</sup></italic> mice to trace EBCs-derived tuft cells. Consistently, about 80% of tuft cells were labeled with tdT (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). These findings confirmed that EBCs serve as the cell origin for the ectopic tuft cells. EBCs can be derived from multiple cell sources including a subpopulation of Scgb1a1<sup>+</sup> club cells (<xref ref-type="bibr" rid="bib43">Yang et al., 2018</xref>). To test whether EBCs derived from the club cell subpopulation give rise to tuft cells, we lineage labeled club cells before exposing <italic>Scgb1a1<sup>CreERT</sup>;R26<sup>Ai14</sup></italic> mice to PR8 virus. 21.0% ± 2.0% tuft cells that were ectopically present in the parenchyma were labeled with tdT when examined at 30 dpi (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>), suggesting that club cells also generate a portion of tuft cells in the lung parenchyma upon viral infection.</p><p>We recently reported expansion of tuft cell in COVID-19 lungs (<xref ref-type="bibr" rid="bib25">Melms et al., 2021</xref>). Upon SARS-CoV-2 infection club and ciliated cells were almost completely ablated (<xref ref-type="bibr" rid="bib7">Fang et al., 2020</xref>), exposing the underlying basal cells in the affected intrapulmonary airways (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). A significant number of the dispositioned basal cells remained proliferative while lodged in the alveoli, presumably initiating EBCs (<xref ref-type="fig" rid="fig3">Figure 3B–C</xref>). Tuft cells were occasionally present in the established EBCs in addition to the airways (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Similar to the EBC-derived tuft cells in influenza-infected mice, the ectopic tuft cells in the parenchyma of COVID-19 lungs co-expressed KRT5 and POU2F3 (<xref ref-type="fig" rid="fig3">Figure 3D</xref>), suggesting a similar differentiation scheme. By contrast, tuft cells in the airways did not express KRT5 (<xref ref-type="fig" rid="fig3">Figure 3E</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>EBCs likely give rise to tuft cells in the parenchyma of COVID-19 lungs.</title><p>(<bold>A</bold>) SARS-CoV-2 infection causes the loss of club and ciliated cells (arrows in a), exposing the underlying basal cells (B) in the small airways. Note the detached basal cells (<bold>C</bold>). (<bold>B</bold>) EBCs proliferate in the parenchyma of COVID-19 lungs. H&amp;E staining shows the presence of EBC clusters in COVID-19 lungs. (<bold>C</bold>) Representative clusters of EBCs are present in COVID-19 lungs. (<bold>D</bold>) Tuft cells within EBCs express both KRT5 and the tuft cell marker POU2F3. (<bold>E</bold>) Solitary tuft cells without KRT5 expression are present in the airways of COVID-19 lung. Abbreviation: bv, blood vessel. Scale bars, 100 μm (<bold>A, B and C</bold>) and 50 μm (<bold>D and E</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78217-fig3-v2.tif"/></fig></sec><sec id="s2-4"><title>Inhibition of Wnt and Notch signaling has opposite effects on the differentiation of EBCs into tuft cells</title><p>We next sought to identify the signaling pathways that can influence tuft cell differentiation from EBCs. Lineage-labeled EBCs were isolated and purified from the lungs of <italic>KRT5-CreERT2;R26<sup>Ai14</sup></italic> mice following viral infection and were expanded using the protocol for culturing basal cells (<xref ref-type="bibr" rid="bib27">Mou et al., 2016</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). The expanded EBCs maintained the lineage tag (tdT<sup>+</sup>) and expressed p63 and Krt5 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). In addition, they also expressed the respiratory protein markers Nkx2.1 and Foxa2 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). We then used the expanded EBCs to assess the impact of major signaling pathways which have been implicated in the determination of cell fate during lung development. The tested pathways include Tgfß/Bmp, Yap, Shh, Wnt, Notch, IL-6, and IL-4/IL-13 (<xref ref-type="bibr" rid="bib1">Ahdieh et al., 2001</xref>; <xref ref-type="bibr" rid="bib3">Barkauskas et al., 2013</xref>; <xref ref-type="bibr" rid="bib13">Ikonomou et al., 2020</xref>; <xref ref-type="bibr" rid="bib17">Lee et al., 2014a</xref>; <xref ref-type="bibr" rid="bib19">Li et al., 2017</xref>; <xref ref-type="bibr" rid="bib28">Nabhan et al., 2018</xref>; <xref ref-type="bibr" rid="bib29">Pardo-Saganta et al., 2015</xref>; <xref ref-type="bibr" rid="bib37">Tadokoro et al., 2014</xref>; <xref ref-type="bibr" rid="bib39">Vaughan et al., 2015</xref>; <xref ref-type="bibr" rid="bib44">Yuan et al., 2019</xref>; <xref ref-type="bibr" rid="bib45">Zacharias et al., 2018</xref>). We observed that treatment with IL-4 or IL-13 promoted tuft cell derivation from EBCs in air-liquid interface (ALI) culture (data not shown), in agreement with the previous reports of IL-4Rα-dependent tuft cell expansion from the intestinal crypts (<xref ref-type="bibr" rid="bib9">Gerbe et al., 2016</xref>; <xref ref-type="bibr" rid="bib40">von Moltke et al., 2016</xref>). Notably, treatment of the WNT signaling activator CHIR9902 blocked the derivation of tuft cells by 35.3% ± 3.1%. Conversely, treatment with the Wnt inhibitor IWR-1 promoted tuft cell differentiation by 32.4% ± 6.4% (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). Inhibition of WNT signaling with the Porcupine inhibitor Wnt-C59 also led to increased tuft cell differentiation of airway basal cells isolated from <italic>Dclk1-GFP</italic> mice (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Consistently, daily injection of Wnt-C59 induced abundant tuft cells in the lung parenchyma following viral infection (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). By contrast, Notch inhibition with the γ-secretase inhibitor Dibenzazepine (DBZ) reduced tuft cell differentiation from EBCs in ALI culture (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Daily DBZ injection also decreased the number of tuft cells in the parenchyma by 63.6% ± 1.5% following viral infection (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). To further confirm the role of Notch signaling in tuft cell derivation, <italic>KRT5-CreERT2;Rbpjk<sup>f/f</sup>;R26<sup>Ai14</sup></italic> mice were infected with PR8 virus and injected with Tmx daily from 14 dpi to 18 dpi to specifically delete the Notch effector <italic>Rbpjk</italic> in EBCs. Consistent with the in vitro finding, tuft cells were barely present in the lung parenchyma of <italic>KRT5-CreERT2;Rbpjk<sup>f/f</sup>;R26<sup>Ai14</sup></italic> mice (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). Together these findings suggest that inhibition of the WNT signaling pathway promotes while Notch signaling inhibition blocks the differentiation of EBCs into tuft cells.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Wnt inhibition promotes EBC differentiation into tuft cells while Notch inhibition has an opposite effect.</title><p>(<bold>A</bold>) Treatment with the WNT signaling inhibitor Wnt-C59 promotes tuft cell differentiation of <italic>Dclk1-GFP</italic> basal cells in ALI culture. (<bold>B</bold>) Wnt-C59 treatment increases the number of tuft cells in the lung parenchyma following viral infection. (<bold>C</bold>) Treatment with the Notch signaling inhibitor DBZ completely blocks tuft cell differentiation of <italic>Dclk1-GFP</italic> basal cells in ALI culture. (<bold>D</bold>) Daily injection of DBZ following PR8 infection dramatically reduces tuft cell derivation in the lung parenchyma. n=4 per group. Data represent mean ± s.e.m. <italic>*</italic>p<italic>&lt;</italic>0.05, ***p&lt;0.001; statistical analysis by unpaired two-tailed Student’s <italic>t</italic>-test. Scale bars, 50 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78217-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Isolation and expansion of Krt5<sup>+</sup> EBCs from the lungs of <italic>Trp63<sup>CreERT2</sup>; R26<sup>Ai14</sup></italic> mice that were infected with PR8 virus.</title><p>(<bold>A</bold>) Schematic illustration depicts the methodology. (<bold>B</bold>) Lineage labeled EBCs are expanded and characterized. (<bold>C</bold>) Quantification of Dclk1<sup>+</sup> cells derived from EBCs at various conditions (Vehicle, 2 μM CHIR99021, 5 μM IWR-1, and 2 μM DBZ) in air-liquid interface (ALI) culture. (<bold>D</bold>) Ablation of Notch effector <italic>Rbpjk</italic> in EBCs blocks differentiation of tuft cells from EBCs. Data represent mean ± s.e.m. <italic>*</italic> p<italic>&lt;</italic>0.05, <italic>**</italic> p<italic>P&lt;</italic>0.01, <italic>***</italic> p<italic>P&lt;</italic>0.001; statistical analysis by unpaired two-tailed Student’s <italic>t</italic>-test. Scale bars, 50 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78217-fig4-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-5"><title>Enhanced generation of <italic>Trp63<sup>CreERT2</sup></italic> lineage labeled alveolar epithelium in <italic>Trpm5<sup>-/-</sup></italic> but not <italic>Pou2f3<sup>-/-</sup></italic> mutants</title><p>Given tuft cell ablation reduces macrophage infiltration in PR8-infected mouse lungs (<xref ref-type="bibr" rid="bib25">Melms et al., 2021</xref>), we asked whether loss of tuft cells improves alveolar regeneration. The first mouse model we examined was <italic>Trpm5</italic> null mutant which demonstrates ~80% reduction of tuft cells in the intestine (<xref ref-type="bibr" rid="bib12">Howitt et al., 2016</xref>). The number of tuft cells was reduced but not significantly following viral infection in the lung parenchyma of <italic>Trp63<sup>CreERT2</sup>;Trpm5<sup>-/-</sup>;R26<sup>Ai14</sup></italic> mice as compared to control mice (<italic>Trp63<sup>CreERT2</sup>;Trpm5<sup>+/-</sup>;R26<sup>Ai14</sup></italic>) (<italic>P</italic>&gt;0.05, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). We did not observe any apparent reduction in the size of Krt5<sup>+</sup> EBC clones in the lung parenchyma (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). Consistently, <italic>KRT5-CreERT2</italic> lineage labeled cells did not contribute to AT1 or AT2 cells no matter Tmx was administered before or after viral infection (data not shown), which is in line with previous studies (<xref ref-type="bibr" rid="bib15">Kanegai et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">Vaughan et al., 2015</xref>). Surprisingly, when Tmx was injected after viral infection, we observed 7.9% ± 1.4% <italic>Trp63<sup>CreERT2</sup></italic> lineage-labeled cells expressed the AT2 cell marker SftpC but not p63 or Krt5 in the areas that surrounded the injured foci, and the number was increased to 19.4%±4.2% in <italic>Trp63<sup>CreERT2</sup>;Trpm5<sup>-/-</sup>;R26<sup>Ai14</sup></italic> mice (<xref ref-type="fig" rid="fig5">Figure 5A</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). Lineagelabeled AT2 cells were further confirmed by Abca3, another mature AT2 cell marker (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>). In addition, lineage-labeled cells also included AT1 epithelium (Hopx<sup>+</sup>, T1α<sup>+</sup>) which was increased in the parenchyma of <italic>Trp63<sup>CreERT2</sup>;Trpm5<sup>-/-</sup>;R26<sup>Ai14</sup></italic> mutants (6.5% ± 0.9% vs 2.5% ± 0.8% at 60 dpi) (<xref ref-type="fig" rid="fig5">Figure 5B</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>). To assess whether <italic>Trpm5<sup>-/-</sup></italic> mice exhibited improved pulmonary mechanics after viral infection, we assessed airway resistance when challenged with increasing concentrations of methacholine. Total respiratory system resistance (Rrs) and central airway resistance (Rn) were significantly attenuated in <italic>Trpm5<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig5">Figure 5C</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Increased generation of <italic>Trp63<sup>CreERT2</sup></italic> labeled alveolar epithelium in <italic>Trpm5</italic> null mutants following PR8 infection.</title><p>(<bold>A</bold>) <italic>Trpm5</italic> deletion leads to the increased presence of tdT<sup>+</sup>SftpC<sup>+</sup>Krt5<sup>-</sup> cells in the lung parenchyma at 60 dpi. (<bold>B</bold>) Increased tdT-labeled AT1 cells in the mutant lungs as compared to controls at 60 dpi. (<bold>C</bold>) Whole lung airway resistance improves in <italic>Trpm5<sup>-/-</sup></italic> mice following viral infection (left panel). Central airway resistance is also reduced following viral infection (right panel). n=7 for WT group, n=9 for <italic>Trpm5<sup>-/-</sup></italic> group. Data represent mean ± s.e.m. <italic>*</italic>p<italic>&lt;</italic>0.05, **p&lt;0.01; statistical analysis by unpaired two-tailed Student’s <italic>t</italic>-test. Scale bars, 100 μm (<bold>A</bold>), 20 µm (<bold>B</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78217-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Increased <italic>Trp63<sup>CreERT2</sup></italic> labeled AT1 and AT2 cells in virus-infected <italic>Trpm5<sup>-/-</sup></italic> mice.</title><p>(<bold>A</bold>) Quantification of tuft cells within EBCs areas established in the lung parenchyma of <italic>Trpm5<sup>+/-</sup></italic> and <italic>Trpm5<sup>-/-</sup></italic> mutants at 30 dpi. (<bold>B</bold>) Extensive Krt5<sup>+</sup> EBCs in the lung parenchyma of controls (<italic>Trp63<sup>CreERT2</sup>;Trpm5</italic><sup>+<italic>/-</italic></sup><italic>;R26<sup>Ai14</sup></italic>) and mutants (<italic>Trp63<sup>CreERT2</sup>;Trpm5<sup>-/-</sup>;R26<sup>Ai14</sup></italic>) at 60 dpi. (<bold>C</bold>) Clusters of lineage-labeled AT2 cells. Note some lineage-labeled cells are SftpC<sup>-</sup> (arrowheads). Also note the same image in <xref ref-type="fig" rid="fig5">Figure 5A</xref>. (<bold>D</bold>) Staining with Abca3 confirms the presence of lineage labeled AT2 cells in <italic>Trp63<sup>CreERT2</sup>;Trpm5<sup>-/-</sup>;R26<sup>Ai14</sup></italic> mutants at 60 dpi. (<bold>E</bold>) Lineage tracing confirms that the presence of lineage labeled AT1 (Hopx<sup>+</sup>) in the parenchyma of <italic>Trp63<sup>CreERT2</sup>;Trpm5<sup>-/-</sup>;R26<sup>Ai14</sup></italic> mutants. Data represent mean ± s.e.m. ns: not significant; statistical analysis by unpaired two-tailed Student’s <italic>t</italic>-test. Scale bars, 100 µm (<bold>B</bold>), 50 μm (<bold>C and D</bold>) and 20 µm (<bold>E</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78217-fig5-figsupp1-v2.tif"/></fig></fig-group><p>We next examined the contribution of <italic>Trp63<sup>CreERT2</sup></italic> lineage-labeled cells to lung regeneration in <italic>Pou2f3<sup>-/-</sup></italic> mice which have no tuft cells (<xref ref-type="bibr" rid="bib21">Matsumoto et al., 2011</xref>). We subjected <italic>Trp63<sup>CreERT2</sup>;Pou2f3<sup>-/-</sup>;R26<sup>Ai14</sup></italic> mutants and controls (<italic>Trp63<sup>CreERT2</sup>;Pou2f3<sup>+/-</sup>;R26<sup>Ai14</sup></italic>) to viral infection followed by continuous Tmx injection from 14 to 18 dpi. In the controls prominent bronchiolization occurred in the parenchyma with the extensive presence of Krt5<sup>+</sup> EBCs (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), and approximately 8% of the lineage-labeled cells co-expressed Sftpc but not Krt5 (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). We did not detect improved contribution of lineage-labeled alveolar epithelium in the mutants as compared to the controls (p&gt;0.05) (<xref ref-type="fig" rid="fig6">Figure 6B</xref>), suggesting that loss of the ectopic tuft cells has no impact on alveolar regeneration initiated by <italic>Trp63<sup>CreERT2</sup></italic> labeled epithelium.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>A complete loss of tuft cell does not increase the generation of <italic>Trp63<sup>CreERT2</sup></italic> labeled alveolar cells following PR8 infection.</title><p>(<bold>A</bold>) Extensive Krt5<sup>+</sup>SftpC<sup>-</sup> EBCs are present in the parenchyma of control (<italic>Trp63<sup>CreERT2</sup>;Pou2f3<sup>+/-</sup>;R26<sup>Ai14</sup></italic>) and mutant (<italic>Trp63<sup>CreERT2</sup>;Pou2f3<sup>-/-</sup>;R26<sup>Ai14</sup></italic>) lungs when examined at 60 dpi following PR8 infection. (<bold>B</bold>) Representative areas show <italic>Trp63<sup>CreERT2</sup></italic> labeled AT2 cells in both control and mutant lungs. Ns: not significant; statistical analysis by unpaired two-tailed Student’s <italic>t</italic>-test. Scale bar, 50 μm (<bold>A</bold>), 100 µm (<bold>B</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78217-fig6-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Tuft cells are observed in the large airways at homeostasis in adults. Here, we showed that tuft cells are present in both large and terminal airways during early postnatal development. In response to severe injuries, tuft cells expanded in the airways and ectopically presented in the parenchyma of severely injured lungs. These tuft cells did not generate other cell lineages. Lineage tracing confirmed that they were derived from EBCs, which was promoted by Wnt inhibition. By contrast, pharmacological or genetic inhibition of Notch signaling blocked EBC differentiation into tuft cells. We confirmed that EBCs (Krt5<sup>+</sup>, p63<sup>+</sup>) do not contribute to alveolar regeneration. Instead, we found a <italic>Trp63<sup>CreERT2</sup></italic> labeled population generated alveolar cells independent of the presence of tuft cells.</p><p>Tuft cells were detected throughout the airways including the terminal airways at around the neonatal stage, and they were no longer present in the terminal airways when examined at P56. Upon viral infection, tuft cells expanded in large airways and re-appeared in terminal airways, suggesting re-activation of developmental signaling during injury-repair. Our pilot screen of signaling inhibitors/activators demonstrated that Wnt blockage resulted in significantly increased differentiation of EBCs towards tuft cells. In consistence, treatment of the Wnt inhibitor Wnt-C59 also led to significant expansion of tuft cells in the airways and parenchyma. Along this line, influenza infection has been shown to cause downregulation of Wnt signaling in mouse lungs (<xref ref-type="bibr" rid="bib11">Hancock et al., 2018</xref>). By contrast, we found that both pharmacological and genetic inhibition of Notch signaling suppressed tuft cell expansion. Additionally, IL-4 and IL-13 treatments increased the derivation of tuft cells from EBCs, which is in contrast to the findings from the co-submitted manuscript where deletion of <italic>Il4</italic> had no impact on tuft cell differentiation. This could be due to the extra IL-4/IL-13 we supplied to the cell culture, which may not be present in an in vivo setting during viral infection. Re-expression of the transcription factor Sox9 has been observed during the repair of the airway epithelium following naphthalene challenge (<xref ref-type="bibr" rid="bib14">Jiang et al., 2021</xref>). Interestingly, Sox9 is expressed by tuft cells as shown by the accompanied manuscript. It will be interesting in future experiments to determine whether Sox9 is required to promote the generation of tuft cells.</p><p>Recent lineage tracing studies indicated that EBCs did not contribute meaningfully to the regenerated alveolar cells (<xref ref-type="bibr" rid="bib15">Kanegai et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">Vaughan et al., 2015</xref>). We also injected Tmx into <italic>KRT5-CreERT2;R26<sup>Ai14</sup></italic> mice after viral infection and did not observe contribution of lineage labeled cells to alveolar epithelium (data not shown). By contrast, we observed significant contribution of <italic>Trp63<sup>CreERT2</sup></italic> lineage labeled cells to the alveolar epithelium when Tmx was injected after viral infection. AT2 cells were recently found to generate p63<sup>+</sup> Krt5<sup>+</sup> basal cells in vitro (<xref ref-type="bibr" rid="bib16">Kathiriya et al., 2022</xref>). It is possible that our strategy labels these AT2 cell-derived basal cell subpopulations during regeneration. However, we did not observe <italic>KRT5-CreERT2</italic> lineage-labeled alveolar epithelium no matter Tmx is injected before or after viral infection. This led us to postulate that we indeed labeled a progenitor cell population that transiently expressed p63 but not Krt5 following viral infection. <italic>Trp63<sup>CreERT2</sup></italic> lineage-labeled progenitor cells have been shown to give rise to AT1 and AT2 cells when Tmx is injected at the very early stage of mouse lung development (embryonic day 10.5) (<xref ref-type="bibr" rid="bib43">Yang et al., 2018</xref>). Therefore, it is possible that subpopulations of AT1/AT2 cells regain the transcription program of fetal lung progenitors and transiently express p63 prior to becoming alveolar cells.</p><p>We observed increased contribution of <italic>Trp63<sup>CreERT2</sup></italic>-labeled cells to the alveolar epithelium in <italic>Trpm5<sup>-/-</sup></italic> but not <italic>Pou2f3<sup>-/-</sup></italic> mutants, suggesting that lung regeneration is independent of the presence of ectopic tuft cells in the parenchyma. Trpm5 is a calcium-activated channel protein that induces depolarization in response to increased intracellular calcium (<xref ref-type="bibr" rid="bib30">Prawitt et al., 2003</xref>). This protein is also expressed in B lymphocytes (<xref ref-type="bibr" rid="bib36">Sakaguchi et al., 2020</xref>). Notably, we observed decreased accumulation of B lymphocytes in the lungs of <italic>Trpm5<sup>-/-</sup></italic> mutants following viral infection (unpublished data, H.H. and J.Q.). It will be interesting in the future to determine whether reduced B lymphocytes facilitate lung regeneration.</p><p>In summary, we demonstrated that tuft cells are present in the airways at the early postnatal stages and later are restricted to the large airways. In response to severe injuries tuft cells expand in the airways and are ectopically present in the parenchyma where EBCs serve as their progenitor cells. Moreover, we identified <italic>Trp63<sup>CreERT2</sup></italic> labeled alveolar epithelial cells arising during lung regeneration independent of tuft cells.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Trp63<sup>CreERT2</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib18">Lee et al., 2014b</xref>; <xref ref-type="bibr" rid="bib17">Lee et al., 2014a</xref> PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25210499/">25210499</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Dr. Jianming Xu (Baylor College of Medicine)</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Tg(<italic>KRT5-CreERT2</italic>)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib34">Rock et al., 2009</xref> PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/19625615/">19625615</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Dr. Brigid Hogan (Duke University); A transgenic mouse strain in which human <italic>KRT5</italic> promoter drives CreERT2</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Scgb1a1<sup>CreERT</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib32">Rawlins et al., 2009</xref><break/> PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/19497281/">19497281</ext-link></td><td align="left" valign="bottom">MGI:3849566</td><td align="left" valign="bottom">Dr. Brigid Hogan (Duke University)</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Pou2f3<sup>CreERT2</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib24">McGinty et al., 2020</xref> PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/32160525/">32160525</ext-link></td><td align="left" valign="bottom">MGI:6755141</td><td align="left" valign="bottom">Dr. Jakob von Moltke (University of Washington)</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Tg(<italic>Trpm5-GFP</italic>)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib5">Clapp et al., 2006</xref><break/> PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16573824/">16573824</ext-link></td><td align="char" char="." valign="bottom">16573824</td><td align="left" valign="bottom">Dr. Tod Clapp (Colorado State University)</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Trpm5<sup>-/-</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib6">Damak et al., 2006</xref><break/> PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16436689/">16436689</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Dr. Robert Margolskee (Mount Sinai)</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Pou2f3<sup>-/-</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib21">Matsumoto et al., 2011</xref><break/> PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21572433/">21572433</ext-link></td><td align="left" valign="bottom">MGI:5140071</td><td align="left" valign="bottom">Dr. Keiko Abe (The University of Tokyo)</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Rbpjk<sup>loxp/loxp</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib10">Han et al., 2002</xref><break/> PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/12039915/">12039915</ext-link></td><td align="left" valign="bottom">MGI:3583755</td><td align="left" valign="bottom">Dr. Tasuku Honjo (Kyoto University)</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">B6.Cg-<italic>Gt(ROSA)26Sor<sup>tm14(CAG-tdTomato)Hze</sup></italic>/J</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib20">Madisen et al., 2010</xref><break/> PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/20023653/">20023653</ext-link></td><td align="left" valign="bottom">MGI: 4436847</td><td align="left" valign="bottom">Jackson Laboratories (#007914, <italic>R26<sup>Ai14</sup></italic>)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Dclk1<break/>(Rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab31704</td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CC10 (E-11)<break/>(Mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">sc-365992</td><td align="left" valign="bottom">1:200; Scgb1a1</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-SCGB1A1<break/>(Rat monoclonal)</td><td align="left" valign="bottom">R&amp;D</td><td align="left" valign="bottom">MAB4218</td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Krt5<break/>(Chicken polyclonal)</td><td align="left" valign="bottom">BioLegend</td><td align="char" char="." valign="bottom">905901</td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Krt5<break/>(Mouse monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab17130</td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Krt5<break/>(Rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab53121</td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-p63<break/>(Rabbit polyclonal)</td><td align="left" valign="bottom">Genetex</td><td align="left" valign="bottom">GTX102425</td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-p63<break/>(Mouse monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab735</td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Acetylated tubulin<break/>(Mouse monoclonal)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">T7451</td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-TTF1<break/>(Rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab76013</td><td align="left" valign="bottom">1:500; Nkx2.1</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-FOXA2<break/>(Mouse monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab60721</td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-POU2F3<break/>(Rabbit polyclonal)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">HPA019652</td><td align="char" char="." valign="bottom">1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-ABCA3<break/>(Rabbit polyclonal)</td><td align="left" valign="bottom">Seven Hills</td><td align="left" valign="bottom">WRAB-70565</td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Hop (E-1)<break/>(Mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">sc-398703</td><td align="left" valign="bottom">1:100; Hopx</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti- Prosurfactant Protein C<break/>(Rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab90716</td><td align="left" valign="bottom">1:500; SftpC</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Pro-SP-C<break/>(Rabbit polyclonal)</td><td align="left" valign="bottom">Seven Hills</td><td align="left" valign="bottom">WRAB-9337</td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-tdTomato<break/>(Goat polyclonal)</td><td align="left" valign="bottom">Biorbyt</td><td align="left" valign="bottom">orb182397</td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Pdpn<break/>(Syrian hamster monoclonal)</td><td align="left" valign="bottom">DSHB</td><td align="char" char="." valign="bottom">8.1.1 c</td><td align="left" valign="bottom">1:500; T1α</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti- Green Fluorescent Protein<break/>(Chicken polyclonal)</td><td align="left" valign="bottom">Fisher (Aves Lab)</td><td align="left" valign="bottom">GFP1020</td><td align="left" valign="bottom">1:200; GFP</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Ki-67<break/>(Rat monoclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="char" char="hyphen" valign="bottom">14-5698-82</td><td align="char" char="." valign="bottom">1:50</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 488 Donkey Anti-Chicken<break/>(Donkey polyclonal)</td><td align="left" valign="bottom">Jackson Immuno Research</td><td align="char" char="hyphen" valign="bottom">703-546-155</td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 488 Donkey Anti-Mouse<break/>(Donkey polyclonal)</td><td align="left" valign="bottom">Jackson Immuno Research</td><td align="char" char="hyphen" valign="bottom">715-545-151</td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Cy5 AffiniPure Donkey Anti-Rat IgG<break/>(Donkey polyclonal)</td><td align="left" valign="bottom">Jackson Immuno Research</td><td align="char" char="hyphen" valign="bottom">712-175-150</td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Cy3 AffiniPure Donkey Anti-Mouse IgM<break/>(Donkey polyclonal)</td><td align="left" valign="bottom">Jackson Immuno Research</td><td align="char" char="hyphen" valign="bottom">715-165-140</td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 488 Donkey anti-Rat IgG<break/>(Donkey polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">A21208</td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 555 Donkey anti-Rabbit IgG<break/>(Donkey polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">A31572</td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 555 Donkey anti-Goat IgG<break/>(Donkey polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">A21432</td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 555 Donkey anti-Mouse IgG<break/>(Donkey polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">A31570</td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 647 Goat anti-Chicken IgG<break/>(Goat polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">A21449</td><td align="char" char="." valign="bottom">1:500</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DBZ</td><td align="left" valign="bottom">Tocris</td><td align="char" char="." valign="bottom">4489</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Wnt-C59</td><td align="left" valign="bottom">Tocris</td><td align="char" char="." valign="bottom">5148</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">CHIR99021</td><td align="left" valign="bottom">Tocris</td><td align="char" char="." valign="bottom">4423</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">IWR-1</td><td align="left" valign="bottom">Tocris</td><td align="char" char="." valign="bottom">3532</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Dorsomorphin</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">P5499</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Verteporfin</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">SML0534</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">GDC-0449</td><td align="left" valign="bottom">Selleckchem</td><td align="left" valign="bottom">S1082</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Dexamethasone</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">D2915</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">3-Isobutyl-1-methylxanthine (IBMX)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">I5879</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Recombinant Il-6</td><td align="left" valign="bottom">Peprotech</td><td align="char" char="ndash" valign="bottom">200–06</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Recombinant Il-4</td><td align="left" valign="bottom">Peprotech</td><td align="char" char="ndash" valign="bottom">200–13</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Recombinant Murine Il-13</td><td align="left" valign="bottom">Peprotech</td><td align="char" char="ndash" valign="bottom">210–13</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">8-Bromoadenosine 3′,5′-cyclic monophosphate (8-Br-cAMP)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">B5386</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Bleomycin</td><td align="left" valign="bottom">Fresenius Kabi</td><td align="char" char="." valign="bottom">63323013610</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Naphthalene</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="char" char="." valign="bottom">84679</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Small Airway Epithelial Cell Medium</td><td align="left" valign="bottom">Lonza</td><td align="left" valign="bottom">CC-3118</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Small Airway Epithelial Cell Medium</td><td align="left" valign="bottom">Promocell medium</td><td align="left" valign="bottom">C-21170</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Complete Pneumacult-ALI medium</td><td align="left" valign="bottom">StemCell Technology</td><td align="char" char="." valign="bottom">05001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Antigen unmasking solution, Citric acid based</td><td align="left" valign="bottom">Vector Laboratories</td><td align="left" valign="bottom">H-3300</td><td align="left" valign="bottom">Antigen retrieval buffer for immunostaining</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Normal donkey serum</td><td align="left" valign="bottom">Jackson Immuno Research</td><td align="char" char="hyphen" valign="bottom">017-000-121</td><td align="left" valign="bottom">Blocking reagent for immunostaining</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mouse models</title><p>All animal studies used a minimum of three mice per group. All mouse studies were approved by Columbia University Medical Center Institutional Animal Care and Use Committees (Approval protocol number AC-AABM6565). <italic>Trp63<sup>CreERT2</sup></italic> (<xref ref-type="bibr" rid="bib18">Lee et al., 2014b</xref>)<italic>, Tg(KRT5-CreERT2)</italic> (<xref ref-type="bibr" rid="bib34">Rock et al., 2009</xref>)<italic>, Rbpjk<sup>loxp/loxp</sup></italic> (<xref ref-type="bibr" rid="bib10">Han et al., 2002</xref>)<italic>, Scgb1a1<sup>CreERT</sup></italic> (<xref ref-type="bibr" rid="bib32">Rawlins et al., 2009</xref>)<italic>, Pou2f3<sup>CreERT2</sup></italic> (<xref ref-type="bibr" rid="bib24">McGinty et al., 2020</xref>)<italic>,</italic> Tg(<italic>Trpm5-GFP</italic>) (<xref ref-type="bibr" rid="bib5">Clapp et al., 2006</xref>), <italic>Trpm5<sup>-/-</sup></italic> (<xref ref-type="bibr" rid="bib6">Damak et al., 2006</xref>)<italic>,</italic> and <italic>Pou2f3<sup>-/-</sup></italic> (<xref ref-type="bibr" rid="bib21">Matsumoto et al., 2011</xref>) mouse strains were previously described. B6.Cg-<italic>Gt(ROSA)26Sor<sup>tm14(CAG-tdTomato)Hze</sup></italic>/J (<italic>R26<sup>Ai14</sup></italic>) (<xref ref-type="bibr" rid="bib20">Madisen et al., 2010</xref>) mouse strain was purchased from The Jackson Laboratory (Stock #007914). All mice were maintained on a C57BL/6 and 129SvEv mixed background and housed in the mouse facility at Columbia University according to institutional guidelines. Eight–12 weeks old animals of both sexes were used in equal proportions.</p></sec><sec id="s4-2"><title>Administration of tamoxifen</title><p>Tamoxifen was dissolved in sunflower seed oil to 20 mg/mL as stock solution. For lineage analysis and genetic targeting, <italic>Pou2f3<sup>CreERT2</sup></italic> mouse strain were administered 2 mg tamoxifen by oral gavage at days 0, 2, and 4 for control or 1 mg tamoxifen by oral gavage at days 14, 17, 20, 23, 25, 27 post-viral infection. <italic>Trp63<sup>CreERT2</sup></italic> mice were administered with tamoxifen at a dose of 0.25 mg/g bodyweight by daily oral gavage for a total five doses as indicated. For <italic>Scgb1a1<sup>CreERT</sup></italic> mice, a period of 10 or 21 days as indicated was used to wash out the residual tamoxifen before any further treatments.</p></sec><sec id="s4-3"><title>Injury models (influenza, bleomycin, and naphthalene)</title><p>For influenza virus infection, 260 plaque forming units (pfu) of influenza A/Puerto Rico/8/1934 H1N1 (PR8) virus were dissolved in 40 µl of RPMI medium and then pipetted onto the nostrils of anesthetized mice, whereupon mice aspirated the fluid directly into their lungs. Post procedure, mice were weighed weekly and monitored for mortality rate. For bleomycin injury, mice were anesthetized and intratracheally instilled with 4 unit/kg body weight of bleomycin hydrochloride. For naphthalene treatment, naphthalene solution (25 mg/ml) was freshly prepared before the procedure by dissolving naphthalene in sunflower seed oil. A single dose of naphthalene was delivered by intraperitoneal injection at 275 mg/kg body weight. For all procedures listed above, the administration of the same volumes of vehicle (PRMI medium or saline or sunflower seed oil) was used as control.</p></sec><sec id="s4-4"><title>Mouse EBC isolation, culture, and differentiation</title><p><italic>KRT5-CreERT2; R26<sup>Ai14</sup></italic> mice were infected with PR8 influenza virus and were administered with tamoxifen intraperitoneally as indicated. At 18 dpi mouse peripheral lungs were dissected and dissociated according to the protocol as previously described (<xref ref-type="bibr" rid="bib3">Barkauskas et al., 2013</xref>; <xref ref-type="bibr" rid="bib35">Rock et al., 2011</xref>). tdT<sup>+</sup> cells were sorted by FACS and cultured using the protocol as previously reported (<xref ref-type="bibr" rid="bib27">Mou et al., 2016</xref>), and the protocol for inducing the differentiation of basal-like cells was previously described (<xref ref-type="bibr" rid="bib8">Feldman et al., 2019</xref>; <xref ref-type="bibr" rid="bib27">Mou et al., 2016</xref>). Air-liquid interface (ALI) culture was used to test the effects of the major signaling pathway inhibitors on the differentiation of EBCs towards tuft and mucous cell lineages. Moreover, tracheal basal cells isolated from <italic>Trpm5-GFP</italic> mice were cultured and tested for drug effects in ALI. The tested inhibitors include the BMP signaling inhibitor Dorsomorphin (5 µM), YAP signaling inhibitor verteporfin (100 nM), NOTCH signaling inhibitor DBZ (2 µM), SHH signaling inhibitor GDC-0449 (1 µM), WNT signaling inhibitor IWR-1 (5 µM), WNT signaling activator CHIR99021 (2 µM) which inhibits glycogen synthase kinase (GSK) 3, IL-6 (10 ng/ml), IL-4 (10 ng/ml) and IL-13 (10 ng/ml) were also used to treat ALI culture of EBCs.</p></sec><sec id="s4-5"><title>Treatment of mice with the Porcupine inhibitor Wnt-C59 and the γ secretase inhibitor DBZ</title><p>Wnt-C59 was resuspended by sonication for 20 minutes in a mixture of 0.5% methylcellulose and 0.1% tween-80. Wnt-C59 (10 mg/kg body weight) or vehicle was administrated via oral gavage from day 14 to 29 post-viral infection (n=4 for each group). For DBZ administration, either vehicle or DBZ was administered intranasally at 30 mmol/kg body weight (n=4 per group) from day 14 to 29 post-viral infection. DBZ was suspended in sterile PBS mixed with 2.5 µg/g body weight dexamethasone.</p></sec><sec id="s4-6"><title>Tissue and ALI culture processing and immunostaining</title><p>Human and mouse lung tissues were fixed in 4% paraformaldehyde (PFA) at 4℃ overnight and then dehydrated and embedded in paraffin for sections (5–7 µm). ALI culture membranes were fixed with 4% PFA for direct wholemount staining or were embedded in OCT for frozen sections. All slides and membranes were stained following the protocol reported previously (<xref ref-type="bibr" rid="bib8">Feldman et al., 2019</xref>; <xref ref-type="bibr" rid="bib27">Mou et al., 2016</xref>). The primary antibodies used for immunostaining are listed in the Resources Table.</p></sec><sec id="s4-7"><title>Pulmonary function assessment</title><p><italic>Trpm5<sup>+/-</sup></italic> and <italic>Trpm5<sup>-/-</sup></italic> mice ( +/- days after viral injury) were anesthetized with pentobarbital (50 mg/kg, i.p.). After surgical anesthesia was achieved, a tracheotomy was performed for the insertion of an 18 G cannula, and mice were immediately connected to a flexiVent (SciReq, Montreal, QC, Canada) with an FX1 module and an in-line nebulizer. Body temperature was monitored and maintained with a thermo-coupled warming blanket and rectal temperature probe. Heart rate was monitored by EKG (electrocardiography). Mice were mechanically ventilated with a tidal volume of 10 mg/kg, frequency of 150 breaths/min, and a positive end expiratory pressure of 3 mmHg. Muscle paralysis was achieved with succinylcholine (10 mg/kg, i.p.) to prevent respiratory effort and to eliminate any contribution of chest wall muscle tone to respiratory measurements. By using the forced oscillation technique, baseline measurements of lung resistance (Rrs and Rn, representing total and central airway resistance) were performed. Resistance was then measured during nebulization of increasing concentrations of methacholine (10 s nebulization, 50% duty cycle). Methacholine dissolved in PBS was nebulized at 0, 6.25, 12.5, 25, and 50 mg/ml and resistance (Rrs and Rn) was measured after each concentration. Values for all measurements represent an average of triplicate measurements. Statistical significance was established by comparing the area under the curve for each mouse.</p></sec><sec id="s4-8"><title>COVID-19 lung specimens</title><p>The lung specimens from deceased COVID-19 patients with short post-mortem interval (PMI) (2.5–9 hr) were obtained from the Biobank at Columbia University Irving Medical Center. All experiments involving human samples were performed in accordance with the protocols approved by the Institutional Review Boards at Columbia University Irving Medical Center.</p></sec><sec id="s4-9"><title>Microscopic imaging and quantification</title><p>Slides were visualized using a ZeissLSM T-PMT confocal laser-scanning microscope (Carl Zeiss). The staining of cells on culture dishes and the staining on transwell membranes were visualized with the Olympus IX81 inverted fluorescence microscope. For quantification of lineage tracing, the lung sections were tiled scanned with 20 X images from at least three mice for each genotype. Cells were counted from at least five sections per mouse including at least three individual lung lobes. The production of various airway epithelial cell types was counted and quantified on at least 5 random fields of view with a 10 X or a 20 X objective, and the average and standard deviation was calculated.</p></sec><sec id="s4-10"><title>Quantification and statistical analysis</title><p>Data are presented as means with standard deviations of measurements unless stated otherwise (n≥3). Statistical differences between samples are assessed with Student two-tailed T-test. p-Values below 0.05 are considered significant (*p&lt;0.05, **p&lt;0.01, ***p&lt;0.001).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Funding acquisition, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con7"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con9"><p>Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con11"><p>Writing - review and editing</p></fn><fn fn-type="con" id="con12"><p>Writing - review and editing</p></fn><fn fn-type="con" id="con13"><p>Writing - review and editing</p></fn><fn fn-type="con" id="con14"><p>Writing - review and editing</p></fn><fn fn-type="con" id="con15"><p>Writing - review and editing</p></fn><fn fn-type="con" id="con16"><p>Writing - review and editing</p></fn><fn fn-type="con" id="con17"><p>Writing - review and editing</p></fn><fn fn-type="con" id="con18"><p>Writing - review and editing</p></fn><fn fn-type="con" id="con19"><p>Writing - review and editing</p></fn><fn fn-type="con" id="con20"><p>Writing - review and editing</p></fn><fn fn-type="con" id="con21"><p>Writing - review and editing</p></fn><fn fn-type="con" id="con22"><p>Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con23"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal studies used a minimum of three mice per group. Mouse studies were approved by Columbia University Medical Center Institutional Animal Care and Use Committees (Approval protocol number AC-AABM6565).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-78217-transrepform1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Data Availability: All data are available in the main text or the supplementary materials and deposited to Dryad <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.0vt4b8h1w">https://doi.org/10.5061/dryad.0vt4b8h1w</ext-link>.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Que</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Alveolar regeneration following viral infection is independent of tuft cells</data-title><source>Dryad Digital Repository</source><pub-id pub-id-type="doi">10.5061/dryad.0vt4b8h1w</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank the colleagues in the Que laboratory for critical input of the study. We also thank Columbia University COVID-19 Hub and the autopsy pathologists who have been fighting on the frontlines and provided us short post-mortem interval (PMI) specimens. Funding: This work is partly supported by R01HL152293, R01HL159675, R01DK120650, R01DK100342 (to JQ), Cystic Fibrosis Foundation Research Grant MOU19G0 (to HM), Harvard Stem Cell Institute Seed Grant (SG-0120-19-00), Charles H Hood Foundation Child Health Research Award (to HM), Discovery Award from the Department of Defense (W81XWH-21-1-0196 to HH) and R21AI163753 (to HH).Research reported in this publication was supported in part by the Office of the Director, NIH Award 1S10OD032447, S10OD020056, P30CA013696 and P30DK132710.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahdieh</surname><given-names>M</given-names></name><name><surname>Vandenbos</surname><given-names>T</given-names></name><name><surname>Youakim</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-gamma</article-title><source>American Journal of Physiology. Cell Physiology</source><volume>281</volume><fpage>C2029</fpage><lpage>C2038</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.2001.281.6.C2029</pub-id><pub-id pub-id-type="pmid">11698262</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bankova</surname><given-names>LG</given-names></name><name><surname>Dwyer</surname><given-names>DF</given-names></name><name><surname>Yoshimoto</surname><given-names>E</given-names></name><name><surname>Ualiyeva</surname><given-names>S</given-names></name><name><surname>McGinty</surname><given-names>JW</given-names></name><name><surname>Raff</surname><given-names>H</given-names></name><name><surname>von Moltke</surname><given-names>J</given-names></name><name><surname>Kanaoka</surname><given-names>Y</given-names></name><name><surname>Frank Austen</surname><given-names>K</given-names></name><name><surname>Barrett</surname><given-names>NA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The cysteinyl leukotriene 3 receptor regulates expansion of IL-25-producing airway brush cells leading to type 2 inflammation</article-title><source>Science Immunology</source><volume>3</volume><elocation-id>eaat9453</elocation-id><pub-id pub-id-type="doi">10.1126/sciimmunol.aat9453</pub-id><pub-id pub-id-type="pmid">30291131</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barkauskas</surname><given-names>CE</given-names></name><name><surname>Cronce</surname><given-names>MJ</given-names></name><name><surname>Rackley</surname><given-names>CR</given-names></name><name><surname>Bowie</surname><given-names>EJ</given-names></name><name><surname>Keene</surname><given-names>DR</given-names></name><name><surname>Stripp</surname><given-names>BR</given-names></name><name><surname>Randell</surname><given-names>SH</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name><name><surname>Hogan</surname><given-names>BLM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Type 2 alveolar cells are stem cells in adult lung</article-title><source>The Journal of Clinical Investigation</source><volume>123</volume><fpage>3025</fpage><lpage>3036</lpage><pub-id pub-id-type="doi">10.1172/JCI68782</pub-id><pub-id pub-id-type="pmid">23921127</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basil</surname><given-names>MC</given-names></name><name><surname>Katzen</surname><given-names>J</given-names></name><name><surname>Engler</surname><given-names>AE</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Herriges</surname><given-names>MJ</given-names></name><name><surname>Kathiriya</surname><given-names>JJ</given-names></name><name><surname>Windmueller</surname><given-names>R</given-names></name><name><surname>Ysasi</surname><given-names>AB</given-names></name><name><surname>Zacharias</surname><given-names>WJ</given-names></name><name><surname>Chapman</surname><given-names>HA</given-names></name><name><surname>Kotton</surname><given-names>DN</given-names></name><name><surname>Rock</surname><given-names>JR</given-names></name><name><surname>Snoeck</surname><given-names>HW</given-names></name><name><surname>Vunjak-Novakovic</surname><given-names>G</given-names></name><name><surname>Whitsett</surname><given-names>JA</given-names></name><name><surname>Morrisey</surname><given-names>EE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The cellular and physiological basis for lung repair and regeneration: past, present, and future</article-title><source>Cell Stem Cell</source><volume>26</volume><fpage>482</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2020.03.009</pub-id><pub-id pub-id-type="pmid">32243808</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clapp</surname><given-names>TR</given-names></name><name><surname>Medler</surname><given-names>KF</given-names></name><name><surname>Damak</surname><given-names>S</given-names></name><name><surname>Margolskee</surname><given-names>RF</given-names></name><name><surname>Kinnamon</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Mouse taste cells with G protein-coupled taste receptors lack voltage-gated calcium channels and SNAP-25</article-title><source>BMC Biology</source><volume>4</volume><elocation-id>7</elocation-id><pub-id pub-id-type="doi">10.1186/1741-7007-4-7</pub-id><pub-id pub-id-type="pmid">16573824</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damak</surname><given-names>S</given-names></name><name><surname>Rong</surname><given-names>M</given-names></name><name><surname>Yasumatsu</surname><given-names>K</given-names></name><name><surname>Kokrashvili</surname><given-names>Z</given-names></name><name><surname>Pérez</surname><given-names>CA</given-names></name><name><surname>Shigemura</surname><given-names>N</given-names></name><name><surname>Yoshida</surname><given-names>R</given-names></name><name><surname>Mosinger</surname><given-names>B</given-names></name><name><surname>Glendinning</surname><given-names>JI</given-names></name><name><surname>Ninomiya</surname><given-names>Y</given-names></name><name><surname>Margolskee</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Trpm5 null mice respond to bitter, sweet, and umami compounds</article-title><source>Chemical Senses</source><volume>31</volume><fpage>253</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1093/chemse/bjj027</pub-id><pub-id pub-id-type="pmid">16436689</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Saqi</surname><given-names>A</given-names></name><name><surname>Qiang</surname><given-names>L</given-names></name><name><surname>Que</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Distinct stem/progenitor cells proliferate to regenerate the trachea, intrapulmonary airways and alveoli in COVID-19 patients</article-title><source>Cell Research</source><volume>30</volume><fpage>705</fpage><lpage>707</lpage><pub-id pub-id-type="doi">10.1038/s41422-020-0367-9</pub-id><pub-id pub-id-type="pmid">32606347</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldman</surname><given-names>MB</given-names></name><name><surname>Wood</surname><given-names>M</given-names></name><name><surname>Lapey</surname><given-names>A</given-names></name><name><surname>Mou</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Smad signaling restricts mucous cell differentiation in human airway epithelium</article-title><source>American Journal of Respiratory Cell and Molecular Biology</source><volume>61</volume><fpage>322</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2018-0326OC</pub-id><pub-id pub-id-type="pmid">30848657</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerbe</surname><given-names>F</given-names></name><name><surname>Sidot</surname><given-names>E</given-names></name><name><surname>Smyth</surname><given-names>DJ</given-names></name><name><surname>Ohmoto</surname><given-names>M</given-names></name><name><surname>Matsumoto</surname><given-names>I</given-names></name><name><surname>Dardalhon</surname><given-names>V</given-names></name><name><surname>Cesses</surname><given-names>P</given-names></name><name><surname>Garnier</surname><given-names>L</given-names></name><name><surname>Pouzolles</surname><given-names>M</given-names></name><name><surname>Brulin</surname><given-names>B</given-names></name><name><surname>Bruschi</surname><given-names>M</given-names></name><name><surname>Harcus</surname><given-names>Y</given-names></name><name><surname>Zimmermann</surname><given-names>VS</given-names></name><name><surname>Taylor</surname><given-names>N</given-names></name><name><surname>Maizels</surname><given-names>RM</given-names></name><name><surname>Jay</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites</article-title><source>Nature</source><volume>529</volume><fpage>226</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1038/nature16527</pub-id><pub-id pub-id-type="pmid">26762460</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>H</given-names></name><name><surname>Tanigaki</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>N</given-names></name><name><surname>Kuroda</surname><given-names>K</given-names></name><name><surname>Yoshimoto</surname><given-names>M</given-names></name><name><surname>Nakahata</surname><given-names>T</given-names></name><name><surname>Ikuta</surname><given-names>K</given-names></name><name><surname>Honjo</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision</article-title><source>International Immunology</source><volume>14</volume><fpage>637</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1093/intimm/dxf030</pub-id><pub-id pub-id-type="pmid">12039915</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hancock</surname><given-names>AS</given-names></name><name><surname>Stairiker</surname><given-names>CJ</given-names></name><name><surname>Boesteanu</surname><given-names>AC</given-names></name><name><surname>Monzón-Casanova</surname><given-names>E</given-names></name><name><surname>Lukasiak</surname><given-names>S</given-names></name><name><surname>Mueller</surname><given-names>YM</given-names></name><name><surname>Stubbs</surname><given-names>AP</given-names></name><name><surname>García-Sastre</surname><given-names>A</given-names></name><name><surname>Turner</surname><given-names>M</given-names></name><name><surname>Katsikis</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Transcriptome analysis of infected and bystander type 2 alveolar epithelial cells during influenza A virus infection reveals in vivo Wnt pathway downregulation</article-title><source>Journal of Virology</source><volume>92</volume><elocation-id>e01325-18</elocation-id><pub-id pub-id-type="doi">10.1128/JVI.01325-18</pub-id><pub-id pub-id-type="pmid">30111569</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howitt</surname><given-names>MR</given-names></name><name><surname>Lavoie</surname><given-names>S</given-names></name><name><surname>Michaud</surname><given-names>M</given-names></name><name><surname>Blum</surname><given-names>AM</given-names></name><name><surname>Tran</surname><given-names>SV</given-names></name><name><surname>Weinstock</surname><given-names>JV</given-names></name><name><surname>Gallini</surname><given-names>CA</given-names></name><name><surname>Redding</surname><given-names>K</given-names></name><name><surname>Margolskee</surname><given-names>RF</given-names></name><name><surname>Osborne</surname><given-names>LC</given-names></name><name><surname>Artis</surname><given-names>D</given-names></name><name><surname>Garrett</surname><given-names>WS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut</article-title><source>Science</source><volume>351</volume><fpage>1329</fpage><lpage>1333</lpage><pub-id pub-id-type="doi">10.1126/science.aaf1648</pub-id><pub-id pub-id-type="pmid">26847546</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikonomou</surname><given-names>L</given-names></name><name><surname>Herriges</surname><given-names>MJ</given-names></name><name><surname>Lewandowski</surname><given-names>SL</given-names></name><name><surname>Marsland</surname><given-names>R</given-names></name><name><surname>Villacorta-Martin</surname><given-names>C</given-names></name><name><surname>Caballero</surname><given-names>IS</given-names></name><name><surname>Frank</surname><given-names>DB</given-names></name><name><surname>Sanghrajka</surname><given-names>RM</given-names></name><name><surname>Dame</surname><given-names>K</given-names></name><name><surname>Kańduła</surname><given-names>MM</given-names></name><name><surname>Hicks-Berthet</surname><given-names>J</given-names></name><name><surname>Lawton</surname><given-names>ML</given-names></name><name><surname>Christodoulou</surname><given-names>C</given-names></name><name><surname>Fabian</surname><given-names>AJ</given-names></name><name><surname>Kolaczyk</surname><given-names>E</given-names></name><name><surname>Varelas</surname><given-names>X</given-names></name><name><surname>Morrisey</surname><given-names>EE</given-names></name><name><surname>Shannon</surname><given-names>JM</given-names></name><name><surname>Mehta</surname><given-names>P</given-names></name><name><surname>Kotton</surname><given-names>DN</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The in vivo genetic program of murine primordial lung epithelial progenitors</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>635</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-14348-3</pub-id><pub-id pub-id-type="pmid">32005814</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>M</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Wei</surname><given-names>Z</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Sung</surname><given-names>HK</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Qiang</surname><given-names>L</given-names></name><name><surname>Ruan</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Whitsett</surname><given-names>JA</given-names></name><name><surname>Ai</surname><given-names>X</given-names></name><name><surname>Que</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Vegf receptor 2 (KDR) protects airways from mucus metaplasia through a Sox9-dependent pathway</article-title><source>Developmental Cell</source><volume>56</volume><fpage>1646</fpage><lpage>1660</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2021.04.027</pub-id><pub-id pub-id-type="pmid">34010630</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanegai</surname><given-names>CM</given-names></name><name><surname>Xi</surname><given-names>Y</given-names></name><name><surname>Donne</surname><given-names>ML</given-names></name><name><surname>Gotts</surname><given-names>JE</given-names></name><name><surname>Driver</surname><given-names>IH</given-names></name><name><surname>Amidzic</surname><given-names>G</given-names></name><name><surname>Lechner</surname><given-names>AJ</given-names></name><name><surname>Jones</surname><given-names>KD</given-names></name><name><surname>Vaughan</surname><given-names>AE</given-names></name><name><surname>Chapman</surname><given-names>HA</given-names></name><name><surname>Rock</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Persistent pathology in influenza-infected mouse lungs</article-title><source>American Journal of Respiratory Cell and Molecular Biology</source><volume>55</volume><fpage>613</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2015-0387LE</pub-id><pub-id pub-id-type="pmid">27689795</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kathiriya</surname><given-names>JJ</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Brumwell</surname><given-names>A</given-names></name><name><surname>Cassandras</surname><given-names>M</given-names></name><name><surname>Le Saux</surname><given-names>CJ</given-names></name><name><surname>Cohen</surname><given-names>M</given-names></name><name><surname>Alysandratos</surname><given-names>KD</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Wolters</surname><given-names>P</given-names></name><name><surname>Matthay</surname><given-names>M</given-names></name><name><surname>Kotton</surname><given-names>DN</given-names></name><name><surname>Chapman</surname><given-names>HA</given-names></name><name><surname>Peng</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Human alveolar type 2 epithelium transdifferentiates into metaplastic KRT5+ basal cells</article-title><source>Nature Cell Biology</source><volume>24</volume><fpage>10</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1038/s41556-021-00809-4</pub-id><pub-id pub-id-type="pmid">34969962</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Bhang</surname><given-names>DH</given-names></name><name><surname>Beede</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>TL</given-names></name><name><surname>Stripp</surname><given-names>BR</given-names></name><name><surname>Bloch</surname><given-names>KD</given-names></name><name><surname>Wagers</surname><given-names>AJ</given-names></name><name><surname>Tseng</surname><given-names>YH</given-names></name><name><surname>Ryeom</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>CF</given-names></name></person-group><year iso-8601-date="2014">2014a</year><article-title>Lung stem cell differentiation in mice directed by endothelial cells via a BMP4-nfatc1-thrombospondin-1 axis</article-title><source>Cell</source><volume>156</volume><fpage>440</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.12.039</pub-id><pub-id pub-id-type="pmid">24485453</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DK</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liao</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014b</year><article-title>The prostate basal cell (bc) heterogeneity and the p63-positive bc differentiation spectrum in mice</article-title><source>International Journal of Biological Sciences</source><volume>10</volume><fpage>1007</fpage><lpage>1017</lpage><pub-id pub-id-type="doi">10.7150/ijbs.9997</pub-id><pub-id pub-id-type="pmid">25210499</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Herriges</surname><given-names>JC</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Mecham</surname><given-names>RP</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Fgf receptors control alveolar elastogenesis</article-title><source>Development</source><volume>144</volume><fpage>4563</fpage><lpage>4572</lpage><pub-id pub-id-type="doi">10.1242/dev.149443</pub-id><pub-id pub-id-type="pmid">29122839</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madisen</surname><given-names>L</given-names></name><name><surname>Zwingman</surname><given-names>TA</given-names></name><name><surname>Sunkin</surname><given-names>SM</given-names></name><name><surname>Oh</surname><given-names>SW</given-names></name><name><surname>Zariwala</surname><given-names>HA</given-names></name><name><surname>Gu</surname><given-names>H</given-names></name><name><surname>Ng</surname><given-names>LL</given-names></name><name><surname>Palmiter</surname><given-names>RD</given-names></name><name><surname>Hawrylycz</surname><given-names>MJ</given-names></name><name><surname>Jones</surname><given-names>AR</given-names></name><name><surname>Lein</surname><given-names>ES</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A robust and high-throughput CRE reporting and characterization system for the whole mouse brain</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>133</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1038/nn.2467</pub-id><pub-id pub-id-type="pmid">20023653</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>I</given-names></name><name><surname>Ohmoto</surname><given-names>M</given-names></name><name><surname>Narukawa</surname><given-names>M</given-names></name><name><surname>Yoshihara</surname><given-names>Y</given-names></name><name><surname>Abe</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Skn-1A (pou2f3) specifies taste receptor cell lineage</article-title><source>Nature Neuroscience</source><volume>14</volume><fpage>685</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1038/nn.2820</pub-id><pub-id pub-id-type="pmid">21572433</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>May</surname><given-names>R</given-names></name><name><surname>Riehl</surname><given-names>TE</given-names></name><name><surname>Hunt</surname><given-names>C</given-names></name><name><surname>Sureban</surname><given-names>SM</given-names></name><name><surname>Anant</surname><given-names>S</given-names></name><name><surname>Houchen</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice</article-title><source>Stem Cells</source><volume>26</volume><fpage>630</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1634/stemcells.2007-0621</pub-id><pub-id pub-id-type="pmid">18055444</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>May</surname><given-names>R</given-names></name><name><surname>Sureban</surname><given-names>SM</given-names></name><name><surname>Hoang</surname><given-names>N</given-names></name><name><surname>Riehl</surname><given-names>TE</given-names></name><name><surname>Lightfoot</surname><given-names>SA</given-names></name><name><surname>Ramanujam</surname><given-names>R</given-names></name><name><surname>Wyche</surname><given-names>JH</given-names></name><name><surname>Anant</surname><given-names>S</given-names></name><name><surname>Houchen</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Doublecortin and CaM kinase-like-1 and leucine-rich-repeat-containing G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively</article-title><source>Stem Cells</source><volume>27</volume><fpage>2571</fpage><lpage>2579</lpage><pub-id pub-id-type="doi">10.1002/stem.193</pub-id><pub-id pub-id-type="pmid">19676123</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGinty</surname><given-names>JW</given-names></name><name><surname>Ting</surname><given-names>HA</given-names></name><name><surname>Billipp</surname><given-names>TE</given-names></name><name><surname>Nadjsombati</surname><given-names>MS</given-names></name><name><surname>Khan</surname><given-names>DM</given-names></name><name><surname>Barrett</surname><given-names>NA</given-names></name><name><surname>Liang</surname><given-names>HE</given-names></name><name><surname>Matsumoto</surname><given-names>I</given-names></name><name><surname>von Moltke</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Tuft-cell-derived leukotrienes drive rapid anti-helminth immunity in the small intestine but are dispensable for anti-protist immunity</article-title><source>Immunity</source><volume>52</volume><fpage>528</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.02.005</pub-id><pub-id pub-id-type="pmid">32160525</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melms</surname><given-names>JC</given-names></name><name><surname>Biermann</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Nair</surname><given-names>A</given-names></name><name><surname>Tagore</surname><given-names>S</given-names></name><name><surname>Katsyv</surname><given-names>I</given-names></name><name><surname>Rendeiro</surname><given-names>AF</given-names></name><name><surname>Amin</surname><given-names>AD</given-names></name><name><surname>Schapiro</surname><given-names>D</given-names></name><name><surname>Frangieh</surname><given-names>CJ</given-names></name><name><surname>Luoma</surname><given-names>AM</given-names></name><name><surname>Filliol</surname><given-names>A</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Ravichandran</surname><given-names>H</given-names></name><name><surname>Clausi</surname><given-names>MG</given-names></name><name><surname>Alba</surname><given-names>GA</given-names></name><name><surname>Rogava</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>SW</given-names></name><name><surname>Ho</surname><given-names>P</given-names></name><name><surname>Montoro</surname><given-names>DT</given-names></name><name><surname>Kornberg</surname><given-names>AE</given-names></name><name><surname>Han</surname><given-names>AS</given-names></name><name><surname>Bakhoum</surname><given-names>MF</given-names></name><name><surname>Anandasabapathy</surname><given-names>N</given-names></name><name><surname>Suárez-Fariñas</surname><given-names>M</given-names></name><name><surname>Bakhoum</surname><given-names>SF</given-names></name><name><surname>Bram</surname><given-names>Y</given-names></name><name><surname>Borczuk</surname><given-names>A</given-names></name><name><surname>Guo</surname><given-names>XV</given-names></name><name><surname>Lefkowitch</surname><given-names>JH</given-names></name><name><surname>Marboe</surname><given-names>C</given-names></name><name><surname>Lagana</surname><given-names>SM</given-names></name><name><surname>Del Portillo</surname><given-names>A</given-names></name><name><surname>Tsai</surname><given-names>EJ</given-names></name><name><surname>Zorn</surname><given-names>E</given-names></name><name><surname>Markowitz</surname><given-names>GS</given-names></name><name><surname>Schwabe</surname><given-names>RF</given-names></name><name><surname>Schwartz</surname><given-names>RE</given-names></name><name><surname>Elemento</surname><given-names>O</given-names></name><name><surname>Saqi</surname><given-names>A</given-names></name><name><surname>Hibshoosh</surname><given-names>H</given-names></name><name><surname>Que</surname><given-names>J</given-names></name><name><surname>Izar</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A molecular single-cell lung atlas of lethal COVID-19</article-title><source>Nature</source><volume>595</volume><fpage>114</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03569-1</pub-id><pub-id pub-id-type="pmid">33915568</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montoro</surname><given-names>DT</given-names></name><name><surname>Haber</surname><given-names>AL</given-names></name><name><surname>Biton</surname><given-names>M</given-names></name><name><surname>Vinarsky</surname><given-names>V</given-names></name><name><surname>Lin</surname><given-names>B</given-names></name><name><surname>Birket</surname><given-names>SE</given-names></name><name><surname>Yuan</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Leung</surname><given-names>HM</given-names></name><name><surname>Villoria</surname><given-names>J</given-names></name><name><surname>Rogel</surname><given-names>N</given-names></name><name><surname>Burgin</surname><given-names>G</given-names></name><name><surname>Tsankov</surname><given-names>AM</given-names></name><name><surname>Waghray</surname><given-names>A</given-names></name><name><surname>Slyper</surname><given-names>M</given-names></name><name><surname>Waldman</surname><given-names>J</given-names></name><name><surname>Nguyen</surname><given-names>L</given-names></name><name><surname>Dionne</surname><given-names>D</given-names></name><name><surname>Rozenblatt-Rosen</surname><given-names>O</given-names></name><name><surname>Tata</surname><given-names>PR</given-names></name><name><surname>Mou</surname><given-names>H</given-names></name><name><surname>Shivaraju</surname><given-names>M</given-names></name><name><surname>Bihler</surname><given-names>H</given-names></name><name><surname>Mense</surname><given-names>M</given-names></name><name><surname>Tearney</surname><given-names>GJ</given-names></name><name><surname>Rowe</surname><given-names>SM</given-names></name><name><surname>Engelhardt</surname><given-names>JF</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Rajagopal</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A revised airway epithelial hierarchy includes CFTR-expressing ionocytes</article-title><source>Nature</source><volume>560</volume><fpage>319</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0393-7</pub-id><pub-id pub-id-type="pmid">30069044</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mou</surname><given-names>H</given-names></name><name><surname>Vinarsky</surname><given-names>V</given-names></name><name><surname>Tata</surname><given-names>PR</given-names></name><name><surname>Brazauskas</surname><given-names>K</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Crooke</surname><given-names>AK</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Solomon</surname><given-names>GM</given-names></name><name><surname>Turner</surname><given-names>B</given-names></name><name><surname>Bihler</surname><given-names>H</given-names></name><name><surname>Harrington</surname><given-names>J</given-names></name><name><surname>Lapey</surname><given-names>A</given-names></name><name><surname>Channick</surname><given-names>C</given-names></name><name><surname>Keyes</surname><given-names>C</given-names></name><name><surname>Freund</surname><given-names>A</given-names></name><name><surname>Artandi</surname><given-names>S</given-names></name><name><surname>Mense</surname><given-names>M</given-names></name><name><surname>Rowe</surname><given-names>S</given-names></name><name><surname>Engelhardt</surname><given-names>JF</given-names></name><name><surname>Hsu</surname><given-names>YC</given-names></name><name><surname>Rajagopal</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dual Smad signaling inhibition enables long-term expansion of diverse epithelial basal cells</article-title><source>Cell Stem Cell</source><volume>19</volume><fpage>217</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2016.05.012</pub-id><pub-id pub-id-type="pmid">27320041</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nabhan</surname><given-names>AN</given-names></name><name><surname>Brownfield</surname><given-names>DG</given-names></name><name><surname>Harbury</surname><given-names>PB</given-names></name><name><surname>Krasnow</surname><given-names>MA</given-names></name><name><surname>Desai</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Single-Cell Wnt signaling niches maintain stemness of alveolar type 2 cells</article-title><source>Science</source><volume>359</volume><fpage>1118</fpage><lpage>1123</lpage><pub-id pub-id-type="doi">10.1126/science.aam6603</pub-id><pub-id pub-id-type="pmid">29420258</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pardo-Saganta</surname><given-names>A</given-names></name><name><surname>Tata</surname><given-names>PR</given-names></name><name><surname>Law</surname><given-names>BM</given-names></name><name><surname>Saez</surname><given-names>B</given-names></name><name><surname>Chow</surname><given-names>RD-W</given-names></name><name><surname>Prabhu</surname><given-names>M</given-names></name><name><surname>Gridley</surname><given-names>T</given-names></name><name><surname>Rajagopal</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Parent stem cells can serve as niches for their daughter cells</article-title><source>Nature</source><volume>523</volume><fpage>597</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1038/nature14553</pub-id><pub-id pub-id-type="pmid">26147083</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prawitt</surname><given-names>D</given-names></name><name><surname>Monteilh-Zoller</surname><given-names>MK</given-names></name><name><surname>Brixel</surname><given-names>L</given-names></name><name><surname>Spangenberg</surname><given-names>C</given-names></name><name><surname>Zabel</surname><given-names>B</given-names></name><name><surname>Fleig</surname><given-names>A</given-names></name><name><surname>Penner</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Trpm5 is a transient Ca2+-activated cation channel responding to rapid changes in [Ca2+]i</article-title><source>PNAS</source><volume>100</volume><fpage>15166</fpage><lpage>15171</lpage><pub-id pub-id-type="doi">10.1073/pnas.2334624100</pub-id><pub-id pub-id-type="pmid">14634208</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rane</surname><given-names>CK</given-names></name><name><surname>Jackson</surname><given-names>SR</given-names></name><name><surname>Pastore</surname><given-names>CF</given-names></name><name><surname>Zhao</surname><given-names>G</given-names></name><name><surname>Weiner</surname><given-names>AI</given-names></name><name><surname>Patel</surname><given-names>NN</given-names></name><name><surname>Herbert</surname><given-names>DR</given-names></name><name><surname>Cohen</surname><given-names>NA</given-names></name><name><surname>Vaughan</surname><given-names>AE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Development of solitary chemosensory cells in the distal lung after severe influenza injury</article-title><source>American Journal of Physiology. Lung Cellular and Molecular Physiology</source><volume>316</volume><fpage>L1141</fpage><lpage>L1149</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00032.2019</pub-id><pub-id pub-id-type="pmid">30908939</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawlins</surname><given-names>EL</given-names></name><name><surname>Okubo</surname><given-names>T</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Brass</surname><given-names>DM</given-names></name><name><surname>Auten</surname><given-names>RL</given-names></name><name><surname>Hasegawa</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Hogan</surname><given-names>BLM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The role of scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium</article-title><source>Cell Stem Cell</source><volume>4</volume><fpage>525</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2009.04.002</pub-id><pub-id pub-id-type="pmid">19497281</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhodin</surname><given-names>J</given-names></name><name><surname>Dalhamn</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1956">1956</year><article-title>Electron microscopy of the tracheal ciliated mucosa in rat</article-title><source>Zeitschrift Fur Zellforschung Und Mikroskopische Anatomie</source><volume>44</volume><fpage>345</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1007/BF00345847</pub-id><pub-id pub-id-type="pmid">13353477</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rock</surname><given-names>JR</given-names></name><name><surname>Onaitis</surname><given-names>MW</given-names></name><name><surname>Rawlins</surname><given-names>EL</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Clark</surname><given-names>CP</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Randell</surname><given-names>SH</given-names></name><name><surname>Hogan</surname><given-names>BLM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Basal cells as stem cells of the mouse trachea and human airway epithelium</article-title><source>PNAS</source><volume>106</volume><fpage>12771</fpage><lpage>12775</lpage><pub-id pub-id-type="doi">10.1073/pnas.0906850106</pub-id><pub-id pub-id-type="pmid">19625615</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rock</surname><given-names>JR</given-names></name><name><surname>Barkauskas</surname><given-names>CE</given-names></name><name><surname>Cronce</surname><given-names>MJ</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Harris</surname><given-names>JR</given-names></name><name><surname>Liang</surname><given-names>JR</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name><name><surname>Hogan</surname><given-names>BLM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition</article-title><source>PNAS</source><volume>108</volume><fpage>E1475</fpage><lpage>E1483</lpage><pub-id pub-id-type="doi">10.1073/pnas.1117988108</pub-id><pub-id pub-id-type="pmid">22123957</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaguchi</surname><given-names>T</given-names></name><name><surname>Okumura</surname><given-names>R</given-names></name><name><surname>Ono</surname><given-names>C</given-names></name><name><surname>Okuzaki</surname><given-names>D</given-names></name><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Okochi</surname><given-names>Y</given-names></name><name><surname>Tanimura</surname><given-names>N</given-names></name><name><surname>Murakami</surname><given-names>M</given-names></name><name><surname>Kayama</surname><given-names>H</given-names></name><name><surname>Umemoto</surname><given-names>E</given-names></name><name><surname>Kioka</surname><given-names>H</given-names></name><name><surname>Ohtani</surname><given-names>T</given-names></name><name><surname>Sakata</surname><given-names>Y</given-names></name><name><surname>Miyake</surname><given-names>K</given-names></name><name><surname>Okamura</surname><given-names>Y</given-names></name><name><surname>Baba</surname><given-names>Y</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Trpm5 negatively regulates calcium-dependent responses in lipopolysaccharide-stimulated B lymphocytes</article-title><source>Cell Reports</source><volume>31</volume><elocation-id>107755</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107755</pub-id><pub-id pub-id-type="pmid">32521253</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tadokoro</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Barak</surname><given-names>LS</given-names></name><name><surname>Bai</surname><given-names>Y</given-names></name><name><surname>Randell</surname><given-names>SH</given-names></name><name><surname>Hogan</surname><given-names>BLM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Il-6/Stat3 promotes regeneration of airway ciliated cells from basal stem cells</article-title><source>PNAS</source><volume>111</volume><fpage>E3641</fpage><lpage>E3649</lpage><pub-id pub-id-type="doi">10.1073/pnas.1409781111</pub-id><pub-id pub-id-type="pmid">25136113</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ualiyeva</surname><given-names>S</given-names></name><name><surname>Hallen</surname><given-names>N</given-names></name><name><surname>Kanaoka</surname><given-names>Y</given-names></name><name><surname>Ledderose</surname><given-names>C</given-names></name><name><surname>Matsumoto</surname><given-names>I</given-names></name><name><surname>Junger</surname><given-names>WG</given-names></name><name><surname>Barrett</surname><given-names>NA</given-names></name><name><surname>Bankova</surname><given-names>LG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Airway brush cells generate cysteinyl leukotrienes through the ATP sensor P2Y2</article-title><source>Science Immunology</source><volume>5</volume><elocation-id>eaax7224</elocation-id><pub-id pub-id-type="doi">10.1126/sciimmunol.aax7224</pub-id><pub-id pub-id-type="pmid">31953256</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaughan</surname><given-names>AE</given-names></name><name><surname>Brumwell</surname><given-names>AN</given-names></name><name><surname>Xi</surname><given-names>Y</given-names></name><name><surname>Gotts</surname><given-names>JE</given-names></name><name><surname>Brownfield</surname><given-names>DG</given-names></name><name><surname>Treutlein</surname><given-names>B</given-names></name><name><surname>Tan</surname><given-names>K</given-names></name><name><surname>Tan</surname><given-names>V</given-names></name><name><surname>Liu</surname><given-names>FC</given-names></name><name><surname>Looney</surname><given-names>MR</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name><name><surname>Rock</surname><given-names>JR</given-names></name><name><surname>Chapman</surname><given-names>HA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury</article-title><source>Nature</source><volume>517</volume><fpage>621</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1038/nature14112</pub-id><pub-id pub-id-type="pmid">25533958</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Moltke</surname><given-names>J</given-names></name><name><surname>Ji</surname><given-names>M</given-names></name><name><surname>Liang</surname><given-names>H-E</given-names></name><name><surname>Locksley</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit</article-title><source>Nature</source><volume>529</volume><fpage>221</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1038/nature16161</pub-id><pub-id pub-id-type="pmid">26675736</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westphalen</surname><given-names>CB</given-names></name><name><surname>Takemoto</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Macchini</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Renz</surname><given-names>BW</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Ormanns</surname><given-names>S</given-names></name><name><surname>Nagar</surname><given-names>K</given-names></name><name><surname>Tailor</surname><given-names>Y</given-names></name><name><surname>May</surname><given-names>R</given-names></name><name><surname>Cho</surname><given-names>Y</given-names></name><name><surname>Asfaha</surname><given-names>S</given-names></name><name><surname>Worthley</surname><given-names>DL</given-names></name><name><surname>Hayakawa</surname><given-names>Y</given-names></name><name><surname>Urbanska</surname><given-names>AM</given-names></name><name><surname>Quante</surname><given-names>M</given-names></name><name><surname>Reichert</surname><given-names>M</given-names></name><name><surname>Broyde</surname><given-names>J</given-names></name><name><surname>Subramaniam</surname><given-names>PS</given-names></name><name><surname>Remotti</surname><given-names>H</given-names></name><name><surname>Su</surname><given-names>GH</given-names></name><name><surname>Rustgi</surname><given-names>AK</given-names></name><name><surname>Friedman</surname><given-names>RA</given-names></name><name><surname>Honig</surname><given-names>B</given-names></name><name><surname>Califano</surname><given-names>A</given-names></name><name><surname>Houchen</surname><given-names>CW</given-names></name><name><surname>Olive</surname><given-names>KP</given-names></name><name><surname>Wang</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dclk1 defines quiescent pancreatic progenitors that promote injury-induced regeneration and tumorigenesis</article-title><source>Cell Stem Cell</source><volume>18</volume><fpage>441</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2016.03.016</pub-id><pub-id pub-id-type="pmid">27058937</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xi</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>T</given-names></name><name><surname>Brumwell</surname><given-names>AN</given-names></name><name><surname>Driver</surname><given-names>IH</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Tan</surname><given-names>V</given-names></name><name><surname>Jackson</surname><given-names>JR</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>DK</given-names></name><name><surname>Gotts</surname><given-names>JE</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name><name><surname>Shannon</surname><given-names>JM</given-names></name><name><surname>Chapman</surname><given-names>HA</given-names></name><name><surname>Vaughan</surname><given-names>AE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Local lung hypoxia determines epithelial fate decisions during alveolar regeneration</article-title><source>Nature Cell Biology</source><volume>19</volume><fpage>904</fpage><lpage>914</lpage><pub-id pub-id-type="doi">10.1038/ncb3580</pub-id><pub-id pub-id-type="pmid">28737769</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Riccio</surname><given-names>P</given-names></name><name><surname>Schotsaert</surname><given-names>M</given-names></name><name><surname>Mori</surname><given-names>M</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>DK</given-names></name><name><surname>García-Sastre</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Cardoso</surname><given-names>WV</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Spatial-Temporal lineage restrictions of embryonic p63+ progenitors establish distinct stem cell pools in adult airways</article-title><source>Developmental Cell</source><volume>44</volume><fpage>752</fpage><lpage>761</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2018.03.001</pub-id><pub-id pub-id-type="pmid">29587145</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>T</given-names></name><name><surname>Volckaert</surname><given-names>T</given-names></name><name><surname>Redente</surname><given-names>EF</given-names></name><name><surname>Hopkins</surname><given-names>S</given-names></name><name><surname>Klinkhammer</surname><given-names>K</given-names></name><name><surname>Wasnick</surname><given-names>R</given-names></name><name><surname>Chao</surname><given-names>CM</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>JS</given-names></name><name><surname>Yao</surname><given-names>C</given-names></name><name><surname>Majka</surname><given-names>S</given-names></name><name><surname>Stripp</surname><given-names>BR</given-names></name><name><surname>Günther</surname><given-names>A</given-names></name><name><surname>Riches</surname><given-names>DWH</given-names></name><name><surname>Bellusci</surname><given-names>S</given-names></name><name><surname>Thannickal</surname><given-names>VJ</given-names></name><name><surname>De Langhe</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Fgf10-Fgfr2B signaling generates basal cells and drives alveolar epithelial regeneration by bronchial epithelial stem cells after lung injury</article-title><source>Stem Cell Reports</source><volume>12</volume><fpage>1041</fpage><lpage>1055</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2019.04.003</pub-id><pub-id pub-id-type="pmid">31056475</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zacharias</surname><given-names>WJ</given-names></name><name><surname>Frank</surname><given-names>DB</given-names></name><name><surname>Zepp</surname><given-names>JA</given-names></name><name><surname>Morley</surname><given-names>MP</given-names></name><name><surname>Alkhaleel</surname><given-names>FA</given-names></name><name><surname>Kong</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Cantu</surname><given-names>E</given-names></name><name><surname>Morrisey</surname><given-names>EE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor</article-title><source>Nature</source><volume>555</volume><fpage>251</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1038/nature25786</pub-id><pub-id pub-id-type="pmid">29489752</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>DZ</given-names></name><name><surname>Guan</surname><given-names>SP</given-names></name><name><surname>Liew</surname><given-names>AA</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lim</surname><given-names>SJ</given-names></name><name><surname>Vincent</surname><given-names>M</given-names></name><name><surname>Lessard</surname><given-names>M</given-names></name><name><surname>Crum</surname><given-names>CP</given-names></name><name><surname>Xian</surname><given-names>W</given-names></name><name><surname>McKeon</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>P63 (+) KRT5 (+) distal airway stem cells are essential for lung regeneration</article-title><source>Nature</source><volume>517</volume><fpage>616</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1038/nature13903</pub-id><pub-id pub-id-type="pmid">25383540</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78217.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Noble</surname><given-names>Paul W</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pammg90</institution-id><institution>Cedars-Sinai Medical Centre</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.03.11.483948" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.03.11.483948"/></front-stub><body><p>In this manuscript, the authors describe the ectopic tuft cells that were derived from lineage-tagged Krt5+ Trp63+ cells post influenza virus infection. These tuft cells do not appear to proliferate or give rise to other lineages in the lung parenchyma. They then claim that Wnt inhibitors increase the number of tuft cells while inhibiting Notch signalling decreases the number of tuft cells within Krt5+ pods after infection in vitro and in vivo. The authors further show that genetic deletion of Trpm5 results in an increase in AT2 and AT1 cells in p63CreER lineage-tagged cells compared to control. Lastly, they demonstrate that depletion of tuft cells caused by genetic deletion of Pou2f3 has no effect on the derivation of AT1 and AT2 cells from the p63+ Krt5- progenitor population, implying that tuft cells play no functional role in this process. This study provides new insights into the role of tuft cells and p63+Krt5- progenitor cells in lung repair.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78217.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Noble</surname><given-names>Paul W</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pammg90</institution-id><institution>Cedars-Sinai Medical Centre</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.03.11.483948">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.03.11.483948v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Alveolar regeneration following viral infection is independent of tuft cells&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Paul Noble as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission. All reviewers agree on the importance of the primary observation that Tuft cells do not contribute to alveolar regeneration after injury. However, substantial concerns regarding the preliminary nature of some of the findings were highlighted. Please address the concerns raised below.</p><p>Essential revisions:</p><p>1) Please analyze which cells p63-CreERT2 labels immediately after PR8 and tamoxifen treatment. Are all the tdTomato labeled cells also Krt5 and p63 positive or are some alveolar epithelial cells or other airway cell types also labeled?</p><p>2) Please also show if p63-CreERT2 labels any cells in the adult lung parenchyma in the absence of injury after tamoxifen treatment.</p><p>3) Please analyze if p63-CreERT2 labels any cells with tdTomato in the absence of injury or after PR8 infection but without tamoxifen treatment.</p><p>4) Please analyze when after PR8 infection do the first p63-CreERT2 labeled tdTomato positive alveolar epithelial cells appear.</p><p>5) A clonal analysis of p63-CreERT2 labeled cells using a confetti reporter might also help interpret the origin of p63-CreERT2 labeled cells.</p><p>6) Lastly could the authors compare the single-cell RNAseq transcription profile of p63-CREERT2 labeled cells immediately after PR8 and tamoxifen treatment and also at 60dpi. A pseudotime analysis and trajectory interference analysis could help elucidate the identity of p63-CreERT2 labeled cells that are actually not ectopic basal progenitor cells.</p><p>7) Origin of tuft cells: Although the authors showed the emergence of ectopic tuft cells derived from labelled p63+ cells after infection, it cannot be ruled out that pre-existing p63+Krt5- intrapulmonary progenitors, as previously reported, can also contribute to tuft cell expansion (Rane et al. 2019; by labelling p63+ cells prior to infection, they showed that the majority of ectopic tuft cells are derived from p63+ cells after viral infection). It would be more informative if the authors show the differentiation of tuft cells derived from p63+Krt5+ cells by tracing Krt5+ cells after infection, which will tell us whether ectopic tuft cells are differentiated from ectopic basal cells within Krt5+ pods induced by virus infection.</p><p>8) Mechanisms of tuft cell differentiation: The authors tried to determine which signalling pathways regulate the differentiation of tuft cells from p63+ cells following infection. Although Wnt/Notch inhibitors affected the number of tuft cells derived from p63+ labelled cells, it remains unclear whether these signals directly modulate differentiation fate. The authors claimed that Wnt inhibition promotes tuft cell differentiation from ectopic basal cells. However, in Figure 3B, Wnt inhibition appears to trigger the expansion of p63+Krt5+ pod cells, resulting in increased tuft cell differentiation rather than directly enhancing tuft cell differentiation. Further, in Figure 3D, Notch inhibition appears to reduce p63+Krt5+ pod cells, resulting in decreased tuft cell differentiation. Importantly, a previous study has reported that Notch signalling is critical for Krt5+ pod expansion following influenza infection (Vaughan et al. 2015; Xi et al. 2017). Notch inhibition reduced Krt5+ pod expansion and induced their differentiation into Sftpc+ AT2 cells. One of the key findings in this manuscript is that Wnt and Notch signaling play a role in Tuft cell specification. All current experiments are based on pharmacological modulation. These need to be substantiated using genetic gain loss of function models. In order to address the direct effect of Wnt/Notch signalling in the differentiation process of tuft cells from EBCs, the authors should provide a more detailed characterization of cellular composition (Krt5+ basal cells, club cells, ciliated cells, AT2 and AT1 cells, etc.) and activity (proliferation) within the pods with/without inhibitors/activators.</p><p>9) Impact of Trpm5 deletion in p63+ cells: It is interesting that Trpm5 deletion promotes the expansion of AT2 and AT1 cells derived from labelled p63+ cells following infection. It would be informative to check whether Trpm5 regulates Hif1a and/or Notch activity which has been reported to induce AT2 differentiation from ectopic basal cells (Xi et al. 2017). Although the authors stated that there was no discernible reduction in the size of Krt5+ pods in mutant mice, it would be interesting to investigate the relationship between AT2/AT1 cell retaining pods and the severity of injury (e.g. large Krt5+ pods retain more/less AT2/AT1 cells compared to small pods. What about other cell types, such as club and goblet cells, in Trpm5 mutant pods? Again, it cannot be ruled out that pre-existing p63+Krt5- intrapulmonary progenitor cells can directly convert into AT2/AT1 cells upon Trpm5 deletion rather than p63+Krt5+ cells induced by infection.</p><p>10) Quantification information and method: Overall, the quantification method should be clarified throughout the manuscript. Further, in the method section, the authors stated that the production of various airway epithelial cell types was counted and quantified on at least 5 &quot;random&quot; fields of view. However, virus infection causes spatially heterogeneous injury, resulting in a difficult to measure &quot;blind test&quot;. The authors should address how they dealt with this issue.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78217.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Please analyze which cells p63-CreERT2 labels immediately after PR8 and tamoxifen treatment. Are all the tdTomato labeled cells also Krt5 and p63 positive or are some alveolar epithelial cells or other airway cell types also labeled?</p></disp-quote><p>We thank the reviewer for the question. To answer the reviewer’s question, we performed PR8 infection (250 pfu) on three <italic>Trp63-CreERT2</italic>;<italic>R26tdT</italic> mice and TMX treatment at days 5 and 7 post viral infection. We didn't perform TMX injection immediately as the mice were sick at a few days post infection. The lung samples were collected at 14 dpi. We observed that tdT<sup>+</sup> cells are present in the airways (<xref ref-type="fig" rid="sa2fig1">Author response image 1A</xref>, B), and it appears that the lineage labeled cells (tdT<sup>+</sup>) include club cells (CC10<sup>+</sup>) that are underlined by tdT+Krt5+ basal cells (<xref ref-type="fig" rid="sa2fig1">Author response image 1C</xref>). We think that these labeled basal cells give rise to club cells. However, we also noticed that rare club cells and ciliated cells (FoxJ1<sup>+</sup>) are labeled by tdT in the areas absent of surrounding tdT<sup>+</sup> basal cells (<xref ref-type="fig" rid="sa2fig1">Author response image 1D</xref>). Moreover, a minor population of tdT<sup>+</sup> SPC<sup>+</sup> cells are present in the terminal airways that were disrupted by viral infection (<xref ref-type="fig" rid="sa2fig1">Author response image 1E</xref> and D). We did not see any pods formed in this experiment and we did not observe any tdT<sup>+</sup> cells in the intact alveoli (uninjured area).</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><p><italic>Trp63-CreERT2</italic> lineage labeled cells in the airways but not alveoli when Tamoxifen was induced at day 5 and 7 after PR8 H1N1 viral infection. <italic>Trp63-CreERT2</italic>;<italic>R26-tdT</italic> mice were infected with PR8 at 250 pfu and Tmx were delivered at a dose of 0.25 mg/g bodyweight by oral gavage. Lung samples were collected and analyzed at 14 dpi. Stained antibodies are as indicated. Scale bar: 100 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78217-sa2-fig1-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>2) Please also show if p63-CreERT2 labels any cells in the adult lung parenchyma in the absence of injury after tamoxifen treatment.</p></disp-quote><p>Dr. Wellington Cardoso’s group demonstrated that <italic>Trp63-CreERT2</italic> only labels very few cells in the airways but not the lung parenchyma in the absence of injury after tamoxifen treatment (Yang et al., 2018). Dr. Ying Yang has revisited the data and she did not observe any labeling in the lung parenchyma (n = 2).</p><disp-quote content-type="editor-comment"><p>3) Please analyze if p63-CreERT2 labels any cells with tdTomato in the absence of injury or after PR8 infection but without tamoxifen treatment.</p></disp-quote><p>We performed the experiment and didn't observe any labeled cells in the lung parenchyma without Tamoxifen treatment (n = 4).</p><disp-quote content-type="editor-comment"><p>4) Please analyze when after PR8 infection do the first p63-CreERT2 labeled tdTomato positive alveolar epithelial cells appear.</p></disp-quote><p>We administered tamoxifen at day 5 and 7 after PR8 infection and harvested lung tissues at day 14. As shown in Figure 1, we observed a few tdT<sup>+</sup> SPC<sup>+</sup> cells in the terminal airways that are disrupted by viral infection. Notably, we did not observe any lineage labeled cells in the intact alveoli (uninjured) in this experiment.</p><disp-quote content-type="editor-comment"><p>5) A clonal analysis of p63-CreERT2 labeled cells using a confetti reporter might also help interpret the origin of p63-CreERT2 labeled cells.</p></disp-quote><p>We thank the reviewer for the suggestion. Our new data demonstrate that a rare population of SPC<sup>+</sup>tdT<sup>+</sup> cells are present in the disrupted terminal airways of <italic>Trp63-CreERT2;R26tdT</italic> mice. Our data in the original manuscript and the new data suggest that the initial SPC<sup>+</sup>;tdT<sup>+</sup> cells are rare because we have to administrate multiple doses of Tamoxifen to label them. Given the less labeling efficiency of confetti than R26tdT mice, it is possible we will not be able to label these SPC<sup>+</sup> cells. Moreover, our original manuscript clearly shows individual clones of SPC<sup>+</sup>tdT<sup>+</sup> cells in the regenerated lung, and they do not seem to compose of multiple clones. Therefore we think that use of confetti mice may not add new information.</p><disp-quote content-type="editor-comment"><p>6) Lastly could the authors compare the single-cell RNAseq transcription profile of p63-CREERT2 labeled cells immediately after PR8 and tamoxifen treatment and also at 60dpi. A pseudotime analysis and trajectory interference analysis could help elucidate the identity of p63-CreERT2 labeled cells that are actually not ectopic basal progenitor cells.</p></disp-quote><p>We appreciated the reviewer’s suggestion and agree that single cell RNA sequencing with pseudotime analysis can provide further information regarding the origin of the lineage labeled alveolar cells of <italic>Trp63-CreERT2;R26tdT</italic> mice. That said, our new data clearly show that <italic>KRT5-CreER</italic> lineage labeled cells do not give rise to AT<sub>1/2</sub> cells as previously described (Kanegai et al., 2016; Vaughan et al., 2015), suggesting that the ectopic basal progenitor cells do not generate alveolar cells. By contrast, <italic>Trp63-CreERT2</italic> lineage labeled cells do give rise to AECs, suggesting that this p63<sup>+</sup> cell population capable of generating AECs are different from Krt5<sup>+</sup> ectopic basal progenitor cells. Our single cell core has an extremely long waiting list due to the pandemic and we hope that our new findings are enough to address the reviewer’s concern without the need of single cell analysis.</p><disp-quote content-type="editor-comment"><p>7) Origin of tuft cells: Although the authors showed the emergence of ectopic tuft cells derived from labelled p63+ cells after infection, it cannot be ruled out that pre-existing p63+Krt5- intrapulmonary progenitors, as previously reported, can also contribute to tuft cell expansion (Rane et al. 2019; by labelling p63+ cells prior to infection, they showed that the majority of ectopic tuft cells are derived from p63+ cells after viral infection). It would be more informative if the authors show the differentiation of tuft cells derived from p63+Krt5+ cells by tracing Krt5+ cells after infection, which will tell us whether ectopic tuft cells are differentiated from ectopic basal cells within Krt5+ pods induced by virus infection.</p></disp-quote><p>We followed the reviewer’s suggestion and performed lineage tracing with <italic>Trp63-CreERT2</italic>;<italic>R26-tdT</italic> mice. Mice were infected with PR8 virus at day0, and Tmx was injected daily between day 14 and 18, and the lung samples were collected at day 30. Our lineage tracing data clearly demonstrated that the majority of tuft cells (Dclk1<sup>+</sup>) are lineage labeled (Figure 2E). Considering the label efficiency by Tmx, we think that the major source of tuft cells are p63<sup>+</sup>Krt5<sup>+</sup> pod cells (EBCs).</p><disp-quote content-type="editor-comment"><p>8) Mechanisms of tuft cell differentiation: The authors tried to determine which signalling pathways regulate the differentiation of tuft cells from p63+ cells following infection. Although Wnt/Notch inhibitors affected the number of tuft cells derived from p63+ labelled cells, it remains unclear whether these signals directly modulate differentiation fate. The authors claimed that Wnt inhibition promotes tuft cell differentiation from ectopic basal cells. However, in Figure 3B, Wnt inhibition appears to trigger the expansion of p63+Krt5+ pod cells, resulting in increased tuft cell differentiation rather than directly enhancing tuft cell differentiation. Further, in Figure 3D, Notch inhibition appears to reduce p63+Krt5+ pod cells, resulting in decreased tuft cell differentiation. Importantly, a previous study has reported that Notch signalling is critical for Krt5+ pod expansion following influenza infection (Vaughan et al. 2015; Xi et al. 2017). Notch inhibition reduced Krt5+ pod expansion and induced their differentiation into Sftpc+ AT2 cells. One of the key findings in this manuscript is that Wnt and Notch signaling play a role in Tuft cell specification. All current experiments are based on pharmacological modulation. These need to be substantiated using genetic gain loss of function models. In order to address the direct effect of Wnt/Notch signalling in the differentiation process of tuft cells from EBCs, the authors should provide a more detailed characterization of cellular composition (Krt5+ basal cells, club cells, ciliated cells, AT2 and AT1 cells, etc.) and activity (proliferation) within the pods with/without inhibitors/activators.</p></disp-quote><p>We thank the reviewer’s constructive suggestions, and we apologize for not clearly explaining our quantitative findings. The quantification data in Figure 3B (revised Figure 4B) are presented as the number of tuft cells per mm<sup>2</sup> Krt5<sup>+</sup> pod area.</p><p>To further confirm the role of Notch/Wnt inhibition in tuft cell derivation, we performed genetic studies, generating <italic>KRT5-CreER</italic>;<italic>Rbpjk<sup>f/f</sup></italic>;<italic>R26-tdT</italic> mice. As shown in the following figure, immunostaining on multiple cell markers showed that <italic>Rbpjk</italic> knockout consistently blocks tuft cell differentiation from pod cells (Figure 4—figure supplement 1). Due to resource limitation, we couldn’t perform <italic>β</italic> -catenin knockout experiments at this moment.</p><disp-quote content-type="editor-comment"><p>9) Impact of Trpm5 deletion in p63+ cells: It is interesting that Trpm5 deletion promotes the expansion of AT2 and AT1 cells derived from labelled p63+ cells following infection. It would be informative to check whether Trpm5 regulates Hif1a and/or Notch activity which has been reported to induce AT2 differentiation from ectopic basal cells (Xi et al. 2017). Although the authors stated that there was no discernible reduction in the size of Krt5+ pods in mutant mice, it would be interesting to investigate the relationship between AT2/AT1 cell retaining pods and the severity of injury (e.g. large Krt5+ pods retain more/less AT2/AT1 cells compared to small pods. What about other cell types, such as club and goblet cells, in Trpm5 mutant pods? Again, it cannot be ruled out that pre-existing p63+Krt5- intrapulmonary progenitor cells can directly convert into AT2/AT1 cells upon Trpm5 deletion rather than p63+Krt5+ cells induced by infection.</p></disp-quote><p>We thank the reviewer for the comments and suggestions. Our new data using <italic>KRT5-CreER</italic> mouse line confirmed that pod cells (Krt5<sup>+</sup>) do not contribute to AT2/AT1 cells, consistent with previous studies (Kanegai et al., 2016; Vaughan et al., 2015). Our data also show that <italic>p63-CreER</italic> lineage labeled AT2/AT1 cells are separated from pod cell area, suggesting pod cells and these AT2/AT1 cells are generated from different cell of origin. We also checked the Notch activity in pod cells in <italic>Trpm5<sup>-/-</sup></italic> mice, and some pod cell-derived cells are Hes1 positive, whereas some are Hes1 negative (<xref ref-type="fig" rid="sa2fig2">Author response image 2</xref>). As indicated in <italic>discussion</italic> we think that AT2/AT1 cells are possibly derived from pre-existing AT2 cells that transiently express p63 after PR8 infection. It will be interesting to test whether Trpm5 regulates Hif1a in this population (p63<sup>+</sup>,Krt5<sup>-</sup>), and this will be our next plan.</p><fig id="sa2fig2" position="float"><label>Author response image 2.</label><caption><title>Representative area staining in <italic>Trpm5<sup>-/-</sup></italic> mice at 30 dpi.</title><p>Area 1: Notch signaling is active (Hes1<sup>+</sup>, arrows) in pod cells following viral infection. Area 2: pod cells exhibit reduced Notch activities. Note few Hes1<sup>+</sup> cells in pods (arrows). Scale bar: 50 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78217-sa2-fig2-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>10) Quantification information and method: Overall, the quantification method should be clarified throughout the manuscript. Further, in the method section, the authors stated that the production of various airway epithelial cell types was counted and quantified on at least 5 &quot;random&quot; fields of view. However, virus infection causes spatially heterogeneous injury, resulting in a difficult to measure &quot;blind test&quot;. The authors should address how they dealt with this issue.</p></disp-quote><p>We clarified that quantification method as suggested. For the in vitro cell culture assays on the signaling pathways, we took pictures from at least five random fields of view for quantification. For lung sections, we tile-scanned the lung sections including at least three lung lobes and performed quantification.</p></body></sub-article></article>